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Betydningen av fysisk helse i rusbehandling 
Rusavhengige har en høy forekomst av somatiske sykdommer i tillegg til ulykker og 
overdoser, og dette gir dem en forventet levealder som er 15-20 år lavere enn friske. 
Utgangspunktet for denne doktorgradsavhandlingen var å dokumentere den fysiske 
helsetilstanden til pasientgruppen, og videre å vurdere om et helhetlig behandlingstilbud 
burde inneholde effektiv trening for å bedre pasientenes fysiske helse. Spesielt var målet med 
de fire studiene i avhandlingen å:
1. Evaluere hvordan nøkkelfaktorer for fysisk helse, som aerob utholdenhet og
muskelstyrke, er hos ruspasienter sammenliknet med friske.
2. Måle hvordan skjeletthelsen er hos amfetaminmisbrukere sammenlignet med friske.
3. Undersøke effekt og gjennomførbarhet av intervalltrening med høy aerob intensitet for
ruspasienter i behandling.
4. Undersøke effekt og gjennomførbarhet av styrketrening med høy intensitet for
ruspasienter i behandling.
Avhandlingen viser at ruspasienter har redusert aerob utholdenhet, målt som maksimalt 
oksygenopptak (VO2max) og gangøkonomi, sammenlignet med friske. Pasientgruppen har også 
redusert muskelstyrke og evne til å utvikle muskelkraft hurtig. I tillegg dokumenterer vi at 
amfetaminavhengige også har en systematisk redusert skjeletthelse i hele kroppen, og at 
omtrent halvparten av pasientene i studien hadde verdier som kvalifiserer til osteopeni eller 
osteoporose. Den svekkede skjeletthelsen sammenfaller med reduksjonen i muskelstyrke og 
evne til å utvikle muskelkraft. Generelt sett kan den fysiske helsen hos ruspasientene 
sammenliknes med hva som typisk observeres hos personer som er 15-20 år eldre.
Resultatene indikerer at pasientgruppen har høy risiko for å utvikle hjerte- og karlidelser, 
visse typer kreft, skjelettproblemer samt forhøyet risiko for tidlig død. Selv om flere årsaker 
trolig bidrar til den svekkede fysiske helsen, er det sannsynlig at inaktivitet spiller en viktig 
rolle. Dette kan begrunnes med at reduksjonen i aerob utholdenhet og muskelstyrke var 
systematisk til stede i pasientgruppen, uavhengig av alder, kjønn og hovedrusmiddel, samt at 
koblingen mellom disse nøkkelfaktorene for fysisk helse og inaktivitet tidligere er 
veldokumentert.  
I doktorgradsavhandlingens to siste studier dokumenterer vi at trening med høy intensitet er 
gjennomførbart i klinikk, og at den fysiske helsen til pasientene kan bedres til et nivå som er 
på linje med det man ser hos friske innenfor dagens behandlingsperiode på tre måneder. 
Reduksjonen i risiko for hjerte-kar sykdommer, andre livsstilsykdommer og tidlig død er 
dermed betydelig redusert. Resultatene viser også at bedringen i den fysiske helsen også kan 
tenkes å ha en gunstig effekt på pasientenes psykiske helse. 
Vi konkluderer med at ruspasienter har systematisk svekket fysisk helse sammenlignet med 
friske. Videre viser vi at effektiv fysisk trening kan bedre den fysiske helsen til 
pasientgruppen til et nivå liknende det man ser hos friske. Strukturert og effektiv trening bør 
derfor bli en del av standard rusbehandling. 
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SUMMARY 
It has been well documented that substance use disorder (SUD) patients suffer a high 
prevalence of cardiovascular disease, other lifestyle related diseases and have a decreased life 
expectancy of 15-20 years. However, their physical health status has been unclear. 
Furthermore, it has been uncertain if physical training, as a part of clinical treatment, could be 
a feasible and good strategy to counteract the patient groups’ physical as well as mental 
challenges. 
The objectives of this thesis were: 
1. To evaluate key components for aerobic endurance and skeletal muscle strength in 
SUD patients. 
2. To assess skeletal properties along with skeletal muscle strength and neuromuscular 
function in the lower extremities of amphetamine users. 
3. Examine the effect and feasibility of high aerobic intensity interval training in SUD 
patients in clinical treatment. 
4. Examine the effect and feasibility of maximal strength training in SUD patients in 
clinical treatment. 
In paper I we observed that SUD patients on average had a reduced aerobic capacity (VO2max) 
(15% for men and 25% for women), walking efficiency (12% for men and 15% for women) 
and maximal strength (30% for men and 33% for women) compared to healthy individuals. 
Such reductions are associated with an elevated risk of cardiovascular disease, cancer, mental 
health and premature death. In paper II we observed that amphetamine users also suffer 
reduced bone mineral density (BMD) (on average 8% for men and 7% for women) at several 
skeletal regions compared to healthy individuals. The impairments were accompanied by 
reduced maximal muscle strength and rate of force development (RFD). In paper III we 
documented the effect and feasibility of a high aerobic intensity training intervention in 
clinical treatment. Following the 8 weeks training intervention the SUD patients improved 
their aerobic capacity by 15 ± 7%, likely resulting in a substantial risk reduction for 
developing cardiovascular disease and other life style related diseases. Similarly as the 
aerobic endurance intervention, we documented the effect and feasibility of a strength training 
intervention in clinical treatment in paper IV. The eight week maximal strength training 
(MST) resulted in large improvements in maximal muscle strength (88 ± 54%) and RFD (82 ± 
29%), likely predominantly due to adaptions in the nervous system. The improvements in 
muscular strength and function are associated with decreased risk of falls and fractures, 
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osteopenia and osteoporosis and improved motor function and quality of life. Additionally, 
both paper III and IV confirmed the attenuation of aerobic endurance and muscular strength in 
SUD patients, before the training was carried out.  
In general, the physical measurements were not associated with the type of primary drug the 
SUD patients were using. This indicates that the systematic physical health reductions SUD 
patients suffer may be a consequence of an inactive lifestyle rather than direct damage by the 
actual drug use. In conclusion, this thesis advocates the importance of effective physical 
training as a part of clinical treatment of SUD patients. 
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INTRODUCTION 
 Substance use disorder 
When describing persons with a harmful use of substances, both researchers and clinicians 
apply the terms substance dependency, substance use, substance abuse and addiction 
interchangeably. However, substance use disorder (SUD) has recently been widely accepted 
as a collective term (1). Not only an individual’s mental and physical health is affected when 
a person develops SUD. Most likely, both family, friends and the larger society also suffer. 
 
Definitions and diagnoses of substance use disorder 
The precursors to substance use are often benign feelings or motives like sociability, 
curiosity, and excitement. However, it can also derive from negative life events, when 
substances are used to distance one-self emotionally from the events. Nevertheless, most 
people using substances do not develop SUD (2, 3). The exact distinction between use, abuse 
and dependence has been an ongoing debate within the field for decades. In recent years, SUD 
has replaced the concepts “abuse” and “dependence” in the diagnostic systems (1, 4). SUD is 
an overarching disorder; independent of type of substance use, the diagnosis is based on the 
same classification criteria. SUD is a complex illness and a precise definition is not yet agreed 
on. It is also unclear at what point the substance use is severe enough to require treatment. 
Several factors must be taken into consideration. There are two classification systems and 
diagnostic criteria manuals used to classify the mental disorders and thereby defining the 
criteria to fulfill the diagnosis of SUD in Europe and USA: ICD-10 and DSM-5 (1). 
ICD-10 (International Classification of Diseases, rev. 10) is a classification system developed 
by the World Health Organization (WHO). The classification system is used in the Norwegian 
health care systems, including the clinic that the participants in these studies were recruited 
from, and hence also used in this thesis. Patients with SUD are classified within ICD-10: F10-
19: Mental and behavioral disorders due to psychoactive substance use. According to ICD-10 
three or more of the following criteria have to be fulfilled, and the criteria must have appeared 
simultaneously during a one year period, before SUD can be diagnosed:  
• A strong desire to take the substance. 
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• Impaired capacity to control the substance consumption (e.g. time of onset, 
termination, time of use, failure at reducing or control substance use). 
• Abstinence symptoms when intake of substances is reduced. 
• Increased tolerance to the effect of the substance. 
• Preoccupations with substance use, other activities are reduced because of substance 
use. 
• Despite of harmful consequences the substance use continues. 
 
The classification system DSM-5 (The diagnostic and Statistical manual of mental disorders, 
Fifth Edition) is a manual published by the American Psychiatric Association. While the 
DSM-5 is the official diagnostic system for mental disorders in the US, the ICD-10 is used 
more widely in Europe and other parts of the world and covers all aspects of health. The two 
classification systems are relatively similar, but awareness of which system is used is 
important since there are differences that can influence the determination of an exact 
diagnose.   
  
A model of development and cause of substance use disorder 
There is a common perception within the field that the interaction between biological, 
psychological and social factors plays a major role in the development, course and treatment 
of the disorder. Each of these factors cannot alone account for the development of health or 
illness. Instead, the interaction between them determines the course of development. 
The WHO emphasizes that SUD can be explained and understood by the biopsychosocial 
model (BPS) (5). The BPS model was first introduced to the medical world by Georg L. 
Engel (6). The model emphasizes the importance of the interaction between biological, 
psychological and social factors in the development of illness. With this model Engel 
challenged the biomedical model of illness by proposing other important factors as cause of 
disease and its consequences. In line with this model, studies have shown that the 
combination of pharmacological and psychosocial treatment provides a better outcome than 
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pharmacological treatment alone (7, 8). SUD is a complex illness, and the BPS model 
provides a good framework for understanding the disorder.  
The biological influences are also complex. Among them are genetic factors, which influence 
the brain reward system and bodily organs (9). Several disorders have a biological origin in an 
inherited genetic vulnerability or disposition. This is observed in twin studies, among them a 
study on development of alcoholism by Ducci & Goldman (10), where the authors state that 
there is a high inheritance factor in vulnerability for developing alcoholism. The effect 
substances has on the bodily organs and our biology is important to understand the 
consequences of substance use, and vital in constructing the ideal treatment regime. 
The psychological component of the BPS model may include factors such as mental health, 
identity, personality, social functioning and significant life events (11, 12).  
The social part of the BPS model emphasizes how factors such as family, social network, 
educational and work status, economy, leisure activities and religion can influence health and 
illness. A childhood characterized by conflicts, bad parent/child relations, violence, substance 
use and abuse is associated with a high vulnerability for development of SUD. A large 
number of persons diagnosed with SUD report child abuse or sexual abuse (13). This does not 
mean that children from stable homes cannot develop SUD, but that other risk factors will be 
causative for them (14). 
 
Prevalence of harmful illicit substance use 
According to the UN World Drug Report (15), 27 million people worldwide are estimated to 
have a SUD due to use of illicit drugs. Approximately 12 million people suffer severe health 
problems due to the drug use, and ~0.2 million deaths are caused by the drug use each year. In 
comparison, 2.3 million deaths are associated with alcohol use (16). 
An epidemiologic survey in the US documented that 2% of the population met the criteria for 
SUD ( 9% alcohol use disorder) within the last 12 months (17), while a review including 27 
community studies in European countries estimated the prevalence of SUD in the population 
to be 3% within the last 12 months (18).  
13 
 
Drug overdoses are estimated to be the cause of ~4% of all deaths among European 15-39 
year olds, and about 75% of fatal overdoses are caused by opioids. An estimated 1.3 million 
were opioid users in Europe in 2012 (19). 
Surveys show that the use of illicit drugs in Norway is somewhat lower than in most other 
countries in Europe. An exception is the use of amphetamine, where Norway is at the average 
European level (20). Although the prevalence is somewhat lower compared to other European 
countries, the consequences of the illicit drug use in Norway are severe. This is due to a high 
rate of injection drug users (21, 22); followed by a high risk of infections, infectious diseases 
(23) and overdoses (24). Between 8600 and 12500 individuals were estimated to inject 
heroine or amphetamine in Norway in 2007 (22). Cannabis is the most used illicit drug in 
Norway. According to the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) 7% of the 15-34 year old population in Norway have tried cannabis during the 
last year, and 2% during the last month (20). Amphetamine is the second most used illicit 
drug in Norway. In the age group 15-34 years 6 % has at some point in life tried 
amphetamines. 
 
Substance use disorder treatment in Norway 
Historically SUD was considered to be a social problem in Norway, and substance treatment 
was part of the social service. Interventions and treatment was given according to the social 
care law (25), which mainly focused on the social welfare of the users.  
In 2004 a reform by the Norwegian government led to a major change in the options given to 
individuals diagnosed with SUD. The reform sought to give the SUD patients the same right 
to treatment as patients with other chronic medical diseases (26). The purpose was to 
emphasize the importance that treatment should evolve into inter-disciplinary specialized 
services embracing biological, psychological end social needs, based on the theory behind the 
BPS model. 
The reform moved responsibility for the treatment of individuals with SUD from the 
municipalities to specialist health care. The state has the overall responsibility for the 
specialist health services, also financially (26). The reform aimed to increase collaboration 
between health care, social services and specialist health care services. 
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In 2012; 29 500 patients with SUD received inter-disciplinary services in Norway. Out of 
these 30% received residential treatment. A survey done by SINTEF (27) on behalf of the 
Norwegian Directorate of Health showed that among the patients who receive residential 
treatment in Norway, 35% was treated for alcohol dependency, 17% had amphetamine as 
their primary drug and 15 % had cannabis as their primary drug. About 70% of the patients in 
treatment are men, 28% of the patients were in the age group 18-29 yrs., and 49% were 
between 30-49 yrs. 
 The gender distribution in Norwegian clinics mirrors the gender distribution globally, both in 
differences in drug abuse and in treatment. Few gender differences appear in adolescence,  
they are more apparent in adulthood (28). Gender differences are seen in multiple factors; 
males and females differ in physiological responses to the drugs (29, 30), the path from drug 
use to dependency (31), the long term health effects from drugs and vulnerability for 
comorbid psychiatric diseases (28, 30, 31).  
Despite restructured policies, use of a range of different treatment approaches and a growing 
body of research concerning different treatment methods, the treatment success and recovery 
rate is low. High relapse rates are common within SUD treatment (32-35). Studies show that 
despite widely available treatment programs approximately 60% of SUD patients will have 
relapsed within 12 months after leaving treatment (3, 36). Relapse has severe consequences 
for SUD patients, abstinence leads to loss of tolerance to the toxic effects, and the risk for 
overdose is high when returning to drug use (37). These challenges show that there is a need 
to search for new efficacious methods for SUD treatment (32, 35). 
The BPS model of treatment is widely accepted within the field today. However, in today’s 
treatment programs it has been challenging to find systematic descriptions of actions towards 
the patients physical health, and the treatment programs does not seem to emphasize this 
particularly. Considering both the challenge with treatment outcomes, and the patients’ 
substantial somatic complaints it is surprising how little attention the patients physical health 
problems receive in a rehabilitation perspective. One possible explanation for this could be 
the diagnose classification systems. Since SUD is classified within the mental health 
disorders, physical health problems might simply have been neglected. 
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Socioeconomic costs of harmful substance use 
Substance use is a major public health problem and causes a large economic burden on the 
social welfare system (38, 39). To estimate the exact economical costs is challenging. Studies 
attempting to do so have little coherent methodology and are difficult to compare (39). This 
also reflects the challenges in defining what costs the substance use leads to from a health and 
crime perspective, death, drug treatment and prevention initiatives, withdrawal from school 
and work etc. Whether the costs are caused by alcohol use and/or illicit drugs are also often 
unclear. Despite these difficulties to calculate the exact cost associated with SUD, estimates 
claim that of the overall costs on society caused by disease, at least 10% can be attributed to 
the consequences of SUD (39, 40). Costs associated with residential treatment are high. The 
patients are often dependent of extensive help from public services both prior to residential 
treatment and after (41).  
Governmental costs associated with SUD treatment are dependent on several factors; 
including length of treatment, education level of employees, number of employees per patient, 
facilities etc., and the costs also vary between the public specialist health care system and the 
private clinics.  
Estimates indicate that the average cost per day in a residential SUD treatment clinic 
(interdisciplinary services) in Norway was NOK 4900 (~ € 560) in 2012. The costs were 
higher in the public specialist health care than in the private clinics. In 2012 each clinic-stay 
had an average cost of NOK 195 000 (~ € 2223). For outpatient treatment, an average 
consultation was estimated to cost NOK 2496 (~ € 285). Here the costs were similar for 
public and private treatment (27).  
Considering the large economic costs associated with SUD treatment, and services following 
treatment, it is clear that optimizing the rehabilitation programs would not only lead to better 
outcomes for patients, but also reduce the overall costs on the society. 
 
Physical health status in patients with substance use disorder 
SUD and poor physical conditions are highly related, and a long term substance use is 
associated with elevated risk of developing physical health problems (36, 42, 43). Persons 
with SUD are frequent users of medical care systems; emergency services, primary health 
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care, hospitals and treatment clinics. A substantial part of these inquiries are caused by 
accidents and overdoses (44), but there is also a high prevalence of hypertension, infections, 
cardiovascular diseases, diabetes (43, 45), cancer (45, 46) and indications of an attenuated 
bone health (47, 48). Despite the knowledge of SUD’s relations to medical challenges there 
are barely any clinical studies identifying the frequency of somatic illnesses among SUD 
patients. A study by Keaney et al. (49) found that three out of four SUD patients, mostly 
heroin addicts, had at least one somatic problem, while another study revealed that the SUD 
patients in their survey suffered four or more somatic diagnoses in addition to their SUD (42). 
It is also noteworthy that persons with SUD have a 15-20 years shorter life expectancy than 
the general population (44, 50). The factors that contribute to the physical health challenges 
are multiple; both the drugs and the lifestyle following the addiction has negative 
consequences.  
Evidence of SUD patients’ physical health status is scarce. Aerobic endurance capacity, 
measured as maximal oxygen consumption (VO2max), is seen as one of the most important and 
basic components of physical health, and is linked to risk of diseases and premature death (51, 
52). Wei et al. (52) observed that a low aerobic endurance capacity resulted in a similar, if not 
larger, relative risk of mortality compared to more recognized risk factors such as diabetes, 
high cholesterol, hypertension and cigarette smoking. An improvement of VO2max is shown to 
reduce the risk of mortality. Myers et al. (51) estimated that an improvement of 1 metabolic 
equivalent (MET) (~3.5 mL·min-1·kg-1) increase in VO2max corresponded to a 12% 
improvement in survival. This was supported by Kodama et al. (53) who observed a decrease 
of 1 MET to be associated with a 13-15% higher risk of all-cause mortality and coronary heart 
disease. 
Muscular strength has in recent years also received recognition as being one of the strongest 
predictors of physical illnesses and premature death (54, 55). Low muscular strength is found 
to be highly associated to falls and fractures (56, 57), reduced bone health (58, 59) poor 
walking efficiency (60), elevated risk of cancer (54) and cardiovascular disease (61). 
Since there is a high prevalence of premature death, cardiovascular diseases and other 
lifestyle related diseases among persons with SUD, assessment of their physical health is 
sought after. If the assessment reveals reduced physical health compared to healthy 
individuals, and indicate an elevated risk of diseases and premature death, effective exercise 
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training should be part of the clinical treatment of the patient group to reduce their health 
risks. 
 
Maximal oxygen consumption 
Research on the SUD patient’s aerobic endurance capacity is sparse. A few studies have 
estimated VO2max from submaximal testing, typically applying a cycling or walking modality 
(62, 63). Mamen et al. (64) measured VO2max in a group of SUD patients in a rehabilitation 
project, which displayed values of 39 (men) and 23 (women) mL·min-1·kg-1, respectively. 
Dolezal et al. (65) measured VO2max in methamphetamine (a derivate of amphetamine) 
dependent individuals, and documented values of 31 (men) and 23 (women) mL·min-1·kg-1, 
respectively. These studies are difficult to compare, due to different measurement methods 
and SUD populations. However, what these studies have in common are low measurement 
results compared to healthy populations, which indeed indicates a population at high risk of 
developing cardiovascular disease and other life style diseases. 
 
Maximal muscle strength and rate of force development 
Together with aerobic endurance, the force generating capacity of skeletal muscle is important 
in assessing an individual’s physical health (54). Maximal muscle strength is typically 
expressed as the one repetition maximum (1RM) a person can attain in a standardized 
movement (66, 67). 1RM refers to the result of several force producing muscles performing 
maximally during a single voluntary effort of a task (67).  
To our knowledge, only one study can point to measurements of muscular strength in SUD 
patients. Dolezal et al. (65) assessed 1RM for both leg press and chest press in a study 
examining the effectiveness and feasibility of an eight week exercise training intervention in 
methamphetamine dependent individuals in residential treatment. The baseline results in this 
study indicated that methamphetamine dependents had an impaired muscular strength. 
Unfortunately, the study lacks comparison with a healthy control group, and because their test 
method is not described in detail, it is difficult to compare with other studies. For health and 
performance purposes, not only the maximal strength is shown to be important, but also the 
ability to develop force rapidly (60, 68). Rate of force development (RFD) is defined as the 
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rate of rise in contractile force at the onset of contraction (69) . The RFD is especially relevant 
in situations or performance where it is not sufficient time to reach maximal force. I.e. having 
a high RFD may be preventing falls and improve motor function and balance (69). RFD is 
typically measured the initial <250ms of a muscle contraction, whilst it may take >300ms to 
reach maximal force (69, 70). Furthermore, the early (<100ms) and late (>200ms) phase of 
the RFD has been shown to reflect different physiological parameters. Whilst the early phase 
is closely linked to the twitch contractile properties of the muscle, the later phase is more 
linked to the maximal strength (71). Recognizing this difference between the various parts of 
the RFD, it may be more or less associated with i.e. maximal strength. Despite being a very 
good measure of functionality and to reflect important factors in the force generating capacity 
of the muscle, measurement of RFD amongst SUD patients appears, to our knowledge, not to 
have been conducted before.  
 
Bone health  
Skeletal health is determined by several factors, including genetics, physical activity, 
hormonal status, level of calcium and vitamin D and cigarette smoking. Impaired skeletal 
health increases the risk of osteoporosis and osteoporotic fractures (72, 73).  
Osteoporosis is a skeletal disease characterized by low bone mass, reduced bone quality and 
deteriorated microarchitecture, which causes increased risk of bone fractures (72, 74). 
Osteoporosis is diagnosed by measurements of bone mineral density (BMD), using Dual X-
ray Absorptiometry (DXA), and osteoporosis is defined as a BMD T-score of less than or 
equal to -2.5 standard deviation below average of a young adult (64). By the WHO and 
Internationally Society for Clinical Densitometry criterion the level of BMD is categorized 
into normal, osteopenia and osteoporosis. Osteopenia is an early sign of bone loss, where 
BMD is lower than normal, causing increased fracture risk compared to normal BMD values. 
Osteopenia is defined as a T-score between -1,5 and -2,5 (73). The first treatment initiative for 
persons measured with low BMD is usually lifestyle changes; like increased physical exercise 
and reduce cigarette smoking along with supplements of calcium and vitamin D (72).  
Bone formation and bone resorption are results from slow metabolic processes. Acute 
changes in bone metabolism are therefore difficult to detect with BMD measurements (75). 
Biochemical markers of bone formation or bone break-down products in serum, like bone 
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formation marker type 1 collagen amino-terminal propeptide (P1NP) and the bone resorption 
marker C-terminal telopeptides of type I collagen (CTX-1) can be used to assess acute or 
short term effects in bone metabolism (75) and also to support findings done by DXA. 
Bone health in amphetamine dependents 
Despite a high prevalence of tooth decay and skeletal fractures among methamphetamine 
users, there is little evidence regarding amphetamine’s effects on the skeletal system (48). A 
weakened skeletal system may also be associated with a poor muscle strength and 
neuromuscular function. The high prevalence of fractures may have been attributed to drug 
related falls and accidents. The possibility that the patients have low BMD is not given much 
attention in research or clinical settings. A few studies have obtained bone measurements of 
methamphetamine users. Low bone quality in the calcaneus was observed among male 
methamphetamine users in a study by Katsuragawa (47), using an achilles ultrasound bone 
densitometer. Another study among male methamphetamine users revealed high prevalence 
of osteoporosis at the lumbar spine assessed with DXA (48). About 50% of the participants in 
this study had osteoporosis or osteopenia in the lumbar spine. These findings indicate that 
methamphetamine use or/and inactivity may lead to poor bone quality and increased risk of 
osteoporosis. 
 
Associations between physical and mental health 
SUD, depression- and anxiety disorders are the most common mental illnesses (76, 77). These 
disorders often appear together and are closely connected (78). Several associations between 
mental health and physical health have been shown (43, 55, 79, 80). In the general population, 
the prevalence of depression is lower among physically active (81). Both aerobic endurance 
and muscular strength are shown to be associated with mental health. Ortega et al. (55) 
showed that strong male adolescents were 15-65% less likely to develop any psychiatric 
diagnosis in a 24-year follow up study than males with low muscular strength. In a study 
evaluating associations between measures of physical activity and mental health, Galper et al. 
(80) showed that an increase in aerobic endurance was associated with lower depressive 
symptomatology for both genders. This was supported in a longitudinal study by Sui et al. 
(82); participants with low aerobic endurance at baseline were associated with larger risk of 
depressive symptoms at follow-up. Given the high prevalence of mental illnesses among SUD 
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patients, developing a good physical health should also be emphasized in SUD treatment 
programs because it may have an effect on the patients’ mental health.  
 
Physical training in clinical treatment 
Physical activity has been a supplement to the SUD treatment programs for decades. 
However, evidence of the efficacy of exercise as an adjunct therapy in SUD treatment is not 
clear (83, 84). The content and physiological effects of already integrated physical activities 
are poorly described (85). There is a clear lack of descriptions of the physical activities that 
are being carried out in clinical treatment, and the intensity and frequency appears to not be 
reported. The activities seem to be random and unstructured (86, 87). There are many 
unanswered questions concerning physical training in SUD treatment programs. Important 
questions that need to be addressed are: What is the rationale for including the training 
intervention in clinical treatment? What is the physical health status to an average SUD 
patient arriving in treatment?  Are effective training methods feasible in a clinical setting, and 
how do the SUD patients respond to training? These important questions need to be answered 
if physical training is to be an integrated part of SUD treatment.  
 
Effective physical training 
High aerobic intensity (85-95% of maximal heart rate (HRmax)) endurance training has been 
shown to be more advantageous for improving aerobic endurance than aerobic training with 
lower intensity. Similarly, strength training with high intensity (85-90% of 1RM) has yielded 
larger improvements in skeletal muscle strength than strength training with lower intensity 
(88, 89). When following these methods carefully, paying attention to their recommended 
frequency, intensity and duration, large improvements are achieved in a few weeks of 
training. The methods have been shown to be feasible and applicable for a range of different 
populations; athletes and untrained, young and old, healthy and people from several patient 
groups (90-94).  
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Aerobic endurance 
Pate and Kriska (95) developed a model describing the three most important factors 
accounting for inter-individual variances in aerobic endurance performance; VO2max, lactate 
threshold (LT) and work economy (WE). Numerous studies have supported this model (66, 
96-98). VO2max is argued to be the most important factor of the three, determining physical 
fitness and success in an aerobic endurance performance (88, 99). 
Maximal oxygen consumption (VO2max): 
VO2max is defined as “the highest rate at which oxygen can be taken up and utilized by the 
body during severe exercise” (95, 100). At increasing work intensities the delivery and use of 
oxygen must match the amount of work performed (101). VO2max represents the maximum 
capacity for energy production through oxidative phosphorylation, and is a recognized 
measure for aerobic capacity (102, 103). The transport of oxygen throughout the circulatory 
system from air to mitochondria depends on several factors; the Fick principle summarizes 
both central and peripheral components, and is an exact physiological definition of VO2max: 
VO2max = Q · (a-vO2diff) 
The Fick’s equation shows that VO2max equals the product of cardiac output (Q) and the 
arterial- venous oxygen difference (a-vO2diff) (101). Q is a product of the heart rate and stroke 
volume of the heart, which represents the amount of blood pumped out of the heart in a given 
time. It has been a long lasting debate what primarily limits VO2max, and consequently which 
factor that should be emphasized during effective training. Although each and every factor 
from air to mitochondria contributes, depending on the situation, it has been argued that Q 
and locomotor muscle blood flow may be the most important factors at sea level. At least Q is 
representing the largest differences between trained and untrained, (88, 104, 105).   
Lactate threshold (LT): 
LT reflects the highest working intensity at which the production and elimination of lactate 
are balanced (67, 88), and is determined by “the fraction of the VO2max that may be sustained 
over an extended period” (95). Lactate is a product of anaerobic carbohydrate metabolism (88, 
96). During continuous exercise above the LT, the concentration of blood lactate starts to 
increase, and the accumulation of lactate in the blood is larger than the elimination. The 
higher workload allowed before the threshold is reached, the greater ability to resist fatigue 
during exercise. This is why the LT, although it is a product of anaerobic metabolism, is a 
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good predictor of aerobic performance (103). Highly trained athletes can have LT values as 
high as 90% of VO2max (106). It is suggested that LT predominantly changes with alterations 
of VO2max (106). 
Work economy (WE): 
The measure of WE refers to the oxygen cost of performing work at a standard submaximal 
workload or the energy expenditure required for a given workload below LT (66, 103). The 
lower the oxygen costs, the better the WE is (66). WE is also an important predictor of 
aerobic performance, especially among groups with homogenous VO2max. This is important 
for endurance athletes, but it also has consequences in daily life and tasks for different patient 
groups where walking the stairs or going to the grocery store might be a challenge. Increased 
muscular strength and RFD, without changes in body mass has been shown to improve WE 
(66, 107, 108).  
WE may also be expressed in relation to the external work produced, then it is commonly 
referred to as work efficiency, mechanical efficiency or walking efficiency, and expressed as 
the percentage of the total chemical energy expended, which contributes to the actual external 
work output (101). Several different patient groups have been found to perform work/exercise 
with lower efficiency of movement compared to healthy controls (60, 109, 110). Walking 
efficiency in humans is approximately 25% in healthy individuals (110).  
 
Training for maximal oxygen consumption improvements 
Improvements in VO2max are shown to be directly related to the intensity, duration and 
frequency of training (96). There has been a long lasting discussion about the importance of 
each factor, different intensity levels, and whether training with low intensity and long 
duration gives the same effect as high intensity and short duration. However, in the last 
decade several studies have shown that high aerobic intensity training gives the highest 
training response in improving VO2max (88, 90, 91, 93). Interval training with high aerobic 
intensity (85-95% of HRmax) has in several studies been shown to be an excellent strategy to 
improve VO2max. A well-documented modality to carry out the high aerobic intensity training 
is four repeated intervals each lasting for four minutes, with three minutes active rest in 
between. This modality offers a simple, feasible and effective approach to carry out the 
training sessions, and has also been documented to be superior to training with moderate 
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(85% of HRmax) and low intensity (70% of HRmax) training across age, pathology and physical 
capacity (88, 93). It is important to separate training with high aerobic intensity from training 
with high work intensity when the aim is to target the oxygen taxing organs, and specifically 
the Q. Intervals between 3-8 minutes have been suggested to represent an ideal length, as the 
time then will be sufficient to reach a high taxation of Q as well as terminating the interval 
before the lactate accumulation produced by anaerobic metabolism will be too high. 
 
Muscular strength 
Training for strength improvements 
In terms of strength improvements, adaptions to training can be divided in two main 
categories; muscular and neural adaptions. Muscular adaptations commonly includes muscle 
hypertrophy, and is typically a result of strength training with a moderate load (~70% 1RM), 
and moderate number of repetitions (10-12) and 5-6 sets (111). Neural adaptions may also 
contribute substantially to a muscle strength increase (89, 112). To target neural adaptations 
the strength training is typically carried out with higher loads and fewer repetitions than if the 
aim is to stimulate to muscle hypertrophy. Maximal strength training (MST) has been defined 
as training with loads corresponding to 85-90% of 1RM, resulting in ~5 repetitions until 
failure. Importantly, the repetitions are carried out with maximal mobilization in the 
concentric part of the movement. MST is associated with minimal hypertrophy, and the neural 
adaptions may include alterations in; motor neuron recruitment, firing frequency, 
synchronization of motor units, coordination, inhibition, co-contractions of antagonist 
muscles (66, 113). MST has been used by healthy populations and multiple patient 
populations with excellent results; it is shown to give large gains in 1RM and RFD and has 
low risk of injuries, likely due to the slow and controlled eccentric phase (59, 114, 115). One 
previous study showed that MST was superior to hypertrophy (conventional) strength training 
with regards to 1RM and exhibited a clear tendency to also yield a larger improvement in 
functionally relevant RFD (115). A vast number of studies have applied MST as a strategy for 
treatment in various patient populations, suggesting that the training indeed should be feasible 
in a clinical setting (59, 60, 109, 114, 116-122). 1RM improvements following a two month 
training intervention, training 3 x week, have typically been in the range of 30-45% increase 
(109, 114, 116-118) accompanied with a 100-150% increase in RFD (109, 114, 117). It is 
likely that the large percentage improvements that are observed in RFD in some of these 
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studies are due to the emphasis on high-intended velocity in the concentric phase, and thus 
maximal firing in the neural system, when carrying out the MST. However, it is not known if 
the large adaptations have taken place in the earlier or later phase of the RFD, as these studies 
have made an average observation from 10% to 90% of peak force. Consequently it remains 
elusive if the training adaptation is more caused by twitch contractile properties or maximal 
strength (71) . 
 
Effects of maximal strength training on aerobic endurance 
Not only has MST shown to yield large improvements in 1RM and RFD, it has also been 
shown in several studies with trained (66, 94, 107) and untrained (115, 123) that it can 
improve aerobic endurance by altering the WE. MST interventions of 8 weeks have typically 
resulted in ~5% improvements in WE (107). The mechanisms responsible for the reduced 
oxygen cost have been shown to be solely in the skeletal muscle, lowering blood flow, but 
leaving the a-vO2diff unaltered (124). Thus, the application of MST should be advocated with 
the potential to both improve the force generating capacity of skeletal muscles and to improve 
the aerobic endurance. 
 
Physical training for patients with substance use disorder 
Recognizing the indications that patients with SUD may have a poor physical health, evident 
as a wide range of life-style related diseases, medical conditions and high risk of premature 
death, using effective physical training may likely reverse, and even restore, some of these 
conditions. However, since the activities in clinical treatment today appear unstructured and 
the effects are scarcely documented, a systematic research approach to evaluate the effects, as 
well as the feasibility, is sought after. Additionally the synergetic effect between physical 
health improvements and mental health improvements appears to be an interesting topic for 
investigation. Importantly, regardless of potential effects on substance use or mental health, 
SUD patients should receive a good clinical treatment for a potential impaired physical health. 
Thus, the aim of this thesis was to evaluate the SUD patients’ physical status, specifically 
through direct assessment of key factors for aerobic endurance, muscular strength and bone 
health. Furthermore the aim was to introduce effective physical training in a clinical setting, 
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and finally consider the overall effects on mental health and implications for various life style 
related diseases.  
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OBJECTIVES AND HYPOTHESES 
 
In paper I the objective was to evaluate VO2max, walking efficiency, 1RM and RFD. 
Our hypotheses were that SUD patients had significantly reduced VO2max, walking efficiency, 
1RM and RFD, compared to an age and gender matched healthy control group. 
In paper II the objective was to assess skeletal properties along with muscle strength and 
neuromuscular force generating capacity in the lower extremities of amphetamine users. 
Our hypotheses were that amphetamine users would have lower bone mass and altered bone 
metabolism compared to healthy age- matched controls. Furthermore, we hypothesized the 
reductions in bone mass would be accompanied with lower 1RM and RFD.  
In paper III the objective was to examine the effect and feasibility of high aerobic intensity 
interval training in SUD patients in clinical treatment. 
Our hypotheses were that SUD patients would improve their VO2max and walking efficiency 
more than a SUD control group receiving conventional rehabilitation. 
In paper IV, the objective was to examine the effect and feasibility of a MST intervention for 
SUD patients in clinical treatment. 
Our hypotheses were that SUD patients would improve 1RM, RFD and efferent neural drive 
more than a SUD control group receiving conventional treatment. 
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METHODS 
 
Subjects 
Patients were recruited from residential long term treatment in a substance use treatment 
clinic over a period of 2 years. All patients that volunteered to participate were diagnosed 
with SUD (ICD-10, F10-F19: Mental and behavioral disorders due to psychoactive substance 
use). In paper I 44 patients, 31 males and 13 women, were included. In paper II 36 patients, 
25 males and 11 females, were included. In these two cross sectional studies the subjects were 
compared with two healthy age- and sex matched reference groups consisting of 25 and 37 
subjects, respectively. Paper I evaluated the SUD patients’ aerobic endurance and muscular 
strength, whilst paper II evaluated the patient groups’ skeletal health. Paper III and IV were 
training studies, investigating the effects of high aerobic intensity interval training and MST, 
respectively. In each of these two training studies, 24 subjects were randomized between a 
training group and a control group receiving conventional treatment. Inclusion criteria are 
described in detail in the respective papers. No injuries or complications were noted in any of 
the studies. The regional ethics committee (REK) approved all four studies, and they were 
carried out in accordance with the Declaration of Helsinki. 
 
Testing 
Measurements of physiological key factors and a battery of psychological questionnaires were 
used for the four papers in the current thesis. 
 
Physiological testing 
Endurance 
Oxygen uptake was measured in SUD patients in paper I and III. Oxygen uptake was 
continuously measured from the start of the warm up until the termination of the VO2max test. 
The oxygen uptake measurements were obtained using the Cortex metamax II portable 
metabolic test system (Cortex Biophysic GmbH, Leipzig, Germany), walking or running on a 
treadmill (Woodway Weil am Rhein, Germany). Oxygen uptake, HRmax, respiratory exchange 
ratio (RER) and ventilation (VE) were monitored in 10 second intervals. For heart rate 
assessment Polar F6TM heart rate monitors were used (Polar Electro, Finland).  
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Oxygen uptake at submaximal workload 
To measure WE and walking efficiency, oxygen consumption at a standard submaximal 
workload was measured. After a 10 minute warm up period, the subjects walked at 4.5 km ∙ h-
1 at 5% inclination on the treadmill for a period of 5 minutes. This workload was chosen to 
target a submaximal load for all participants; they all showed steady state oxygen uptake 
values at this load. 
In paper I we calculated the energy input and output to determine the net walking efficiency, 
while in paper III the average oxygen consumption at a given workload for the last minute of 
this period was recorded as the WE. The measurement procedures are described in detail in 
paper I and III. 
 
Maximal oxygen consumption 
Immediately after the submaximal workload, the subjects progressed into the VO2max test. The 
incline was kept at 5% while velocity was increased by 1 km ∙ h-1 every minute until 
exhaustion. Encouragement was given towards the end of the test. VO2max, RER, and VE were 
calculated averaging the three highest continuous ten second values. One or more of the 
following criteria for reaching VO2max were used: 1) If the oxygen consumption reached a 
plateau despite further increases in workload, 2) A RER above 1.10 and 3) Lactate 
concentration in blood > 7mmol. These criteria have previously been used in VO2max testing 
(125). 
 
Lactate concentration in blood 
Lactate concentration in blood was measured using a Biosen C_line (EKF Diagnostics 
GmbH, Barleben, Germany) analyzer. Blood from the patient’s fingertip was sampled for 
analysis of blood lactate within one minute after the end of the VO2max test. 
 
Muscle strength 
1RM and RFD were measured in paper I, II and IV. Additionally, the strength testing in paper 
IV also included measurements of efferent drive.  
Maximal muscle strength 
1RM was predominantly measured in a hack squat apparatus. Paper IV also included a 1RM 
test in a plantar flexion apparatus. In the hack squat machine (impulse Fitness IT7006, 
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Shandong, China) the subjects were in a standing position angled 45° to vertical. From the 
standing position the participants moved eccentrically down to 90° knee angle position before 
the concentric movement (figure 1). The hack squat was chosen because, in contrast to leg 
press, the resistance would be on the participants shoulders. Thus, following training it would 
include stress not only on the SUD patients lower extremity, but also on the spine and lower 
back in the upper body. In the plantar flexion test, the participants had a seated position in a 
calf rise machine (Impulse Health Tech IT7005, Shandong, China), and performed their lifts 
from an ankle joint angle of ~20° dorsiflexion in the lower position, up to ~30° plantar flexion 
in the upper position, respectively. Before the test started, the subjects were familiarized with 
the lifting procedures and performed two warm-up sets. For both hack squat and plantar 
flexion, 1RM was achieved by increasing the load by five to ten kg until the subject was not 
able to complete the lift. A three to four minutes rest was given between each trial, and correct 
joint angles were ensured by marking the respective joint angle positions on the apparatus 
with a tape. 1RM was achieved within six to nine trials, and the highest load completed was 
recorded as 1RM. Importantly, only the last three to four lifts were higher than 80% of 1RM 
to prevent fatigue.  
 
 
 
Figure 1. Hack squat exercise machine and the positioning during testing and training. Reprint with permission 
from Mosti et al. 2013 (59). 
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Rate of force development (RFD) 
RFD was recorded using the hack squat machine and a force platform at 2000Hz (9286AA, 
Kistler, Switzerland) attached to the foot plate. Each subject was given three attempts with a 
load corresponding to 80% of pretest 1RM, only the best trial was used for analyzes. The 
subjects were instructed to move slowly down to a knee joint angle of 90°, and then mobilize 
maximally in the concentric phase of the movement. These instructions were given to ensure 
maximal mobilization of the nervous system. Three minutes rest was given between each 
trial. The highest concentric force was recorded as peak force and RFD was calculated 
between 10% and 90% of peak force. 
 
Efferent drive 
Since MST was primarily applied to induce neural adaptions, measurements of the first 
volitional waves (V-waves) (to indicate possible efferent drive adaptions) were assessed 
before and after training intervention in paper III. With the subjects seated in a fixed version 
of the plantar flexion apparatus for isometric muscle contractions, reflex potentials were 
evoked by a current stimulator (DS7AH, Digitimer, Welwyn Garden City, UK), in the tibial 
nerve, in the popliteal fossa. The electrical current was delivered by gel-coated (Lectron 2 
conductive gel, Pharmaceutical innovations INC, Newark, NJ, USA) bipolar felt pad 
electrodes,  25 mm between tips, 8 mm diameter (Digitimer, Welwyn Garden City, UK). 
Evoked potentials were recorded through self-adhesive AG/AgCI electrodes (Ambu, M-00-
S/50, Ballerup, Denmark) placed as recommended by SENIAM (126) on muscle soleus, m. 
gastrocnemius medialis and m. gastrocnemius lateralis.  
For explicit details on the assessment of V-waves and the search for maximal M-wave 
amplitude see paper IV.  
 
Skeletal properties and body composition 
Dual X-ray absorptiometry (DXA) 
The most widely used measurement technique for evaluating bone mass is DXA. The 
technique is used both in research and in clinical settings, and serves as the primary diagnostic 
tool of osteoporosis (127, 128). The regions for measurements in study II were lumbar spine 
(L1-L4), the hip region and whole body, which are clinically relevant sites for BMD 
measurements. DXA is based on areal quantification of bone mass, therefore accuracy in 
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subject positioning during the scan is important to minimize data variance. The DXA 
measurements of BMD and bone mineral content (BMC) were all performed in the same 
DXA machine (Hologic Discovery, S/N 83817). All DXA scans were carried out by the same 
certified technician to ensure standardized procedures between subjects. 
 
Trabecular bone score (TBS) 
TBS reflects the structural condition of the bone microarchitecture and is an estimate of bone 
quality (129). Since TBS data are estimates of trabecular bone structure within the cortical 
bone envelope, they provide supplemental information to traditional bone mass parameters. 
TBS is measured at the lumbar spine, and because DXA does not directly measure TBS, the 
estimates are performed by using the TBS iNsight® Software version 1.8 (Med-Imaps, 
Pessac, France).  
 
Muscle mass and fat percentage 
The whole body DXA scans enables calculation of soft-tissue composition, such as fat mass 
and lean mass. During the DXA scan, two x-ray beams at two different energy levels passes 
through body tissues and the beams distinct each elemental composition. The distinctive 
profile of bone, fat, and lean tissue allows the DXA scans to visualize and separate each tissue 
(130).  
 
Markers of bone metabolism 
Blood samples (5 ml) were drawn by venipuncture with stasis and collected on vacuum tubes 
for serum. Serum level of the bone formation marker P1NP was determined by 
radioimmunoassay (Orion Diagnostica, Espoo, Finland). Concentration of the bone resorption 
marker CTX was determined by a Serum CrossLaps enzyme-linked immunosorbent assay 
(ELISA) (Nordic Bioscience Diagnostics A/S, Herlev, Denmark). Serum levels of 25-hydroxy 
vitamin D3 were determined by radioimmunoassay (RIA) (DIAsource, Louvain-la-Neuve, 
Belgium), using the manufacturer’s procedure and controls. The timing of the blood sample 
collection and the participants fasting state can interfere with the experimental results. The 
bone resorption marker CTX is particularly sensitive to such variations. Standardizes 
procedures was used in order to prevent such errors. 
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Psychometric variables 
EuropASI addiction severity index 
EuropASI (131) was used to get an overview of the extent of drug use. The index quantifies 
which substances the subject has used, age of debut and years of use. 
 
Insomnia severity index (ISI) 
ISI is composed of 7 items targeting different categories of sleep disturbance severity. The 
items are rated at a five-point Likert scale (0-4) and summed up to provide a total score 
ranging from 0-28, where a higher score indicate more severe insomnia. The score categories 
are 0-7 (no clinically significant insomnia), 8-14 (subthreshold insomnia), 15-21 (clinical 
insomnia, moderate severity) and 22-28 (clinical insomnia, severe) (132). 
 
Hospital anxiety and depression scale (HAD) 
The HAD self-assessment scale consists of a fourteen item scale, where seven items relate to 
anxiety and seven relate to depression. On the subscales for anxiety and depression a score of 
0-7 is regarded to be within the normal range, a score of 8-10 is considered signs of a mood 
disorder, while a score of 11 or higher implies a probable presence of a mood disorder (133). 
 
Training 
High aerobic intensity interval training: 
In paper III the training intervention group performed high aerobic intensity interval training 
on a treadmill. The training group trained three times a week for eight weeks and all training 
sessions were supervised. The training sessions were organized in intervals: after a ten minute 
warm up, the patients performed four intervals of four minutes duration at a high aerobic 
intensity (90-95% of HRmax), interrupted by three minutes recovery periods (~70% of HRmax). 
As the subjects improved, velocity and incline were increased to meet the targeted heart rate. 
The subjects were required to attend at least 20 out of 24 training sessions in order to be 
included in the data analyzes. 
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Maximal strength training: 
The MST intervention in paper IV consisted of two exercises, hack squat and plantar flexion. 
Both exercises consisted of four sets of four to five repetitions, corresponding to 85-90% of 
1RM. If the participants were able to complete five repetitions or more in one set, the training 
load was increased with five kg in the following set. Since the intended velocity of the 
concentric phase of movement is known to be of importance for the training adaptions (66), 
both exercises were conducted with a slow controlled movement in eccentric phase, a short, 
less than a second stop, and then maximal mobilization of force in the concentric movement. 
As for the testing, hack squat was performed with 90° knee joint angle, while the plantar 
flexion exercise was performed from an ankle joint angle of ~20° dorsiflexion up to ~30° 
plantar flexion. Every training session was supervised to ensure proper technique and 
progression during the exercises. The MST procedure has been described previously (66, 
113). 
 
Statistical analysis 
All statistical analyses were performed using the software program IBM SPSS version 20 or 
21 (Statistical Package for Social Science, Chicago, USA). All figures were created using 
GraphPad Prism 5 (San Diego, USA). 
 
Paper I: To determine if the data was normally distributed a Q-Q plot was used. Independent 
samples T-test was used to compare differences between the SUD patient group and the 
healthy reference group. Correlations between primary substance use, gender, age, substance 
use history and physical capacity were analyzed using linear Pearson correlation regression 
analyses.  
 
Paper II: Levene’s test of homogeneity of variance was used to test the data for normal 
distribution. One-way analysis of variance (ANOVA) was used to detect between group 
differences, using the Tukey post hoc test to correct for multiple testing or by Mann-Whitney 
U test when normal distribution could not be assumed. Correlations between groups were 
established using linear Pearson correlation regression analysis. 
 
Paper III: To determine if the data was normally distributed a Q-Q plot was used. Repeated 
measures ANOVAs (2 (group) x 2 training status) were used to determine differences 
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between groups following training. Unpaired and paired t-tests were used to detect differences 
between groups at baseline and within group following training, respectively. 
 
Paper IV: To determine if the data was normally distributed a Q-Q plot was used. Independent 
t-tests were used to detect between groups differences before training, whilst paired t-tests 
were used to detect within group differences with training. Between groups differences 
following training were identified using two-way repeated ANOVAS. Linear correlations 
were identified with the use of the Pearson test for linear regression.  
 
All studies used two tailed significance levels of p < 0.05. Data are reported as mean values 
and standard deviations (SD), unless otherwise stated.  
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SUMMARY OF RESULTS 
Paper I 
x SUD patients had a significantly (p<0.01) reduced VO2max compared to the healthy 
reference group; females and males displayed group average reductions of 25% and 
15%, respectively.  
x The SUD patients WE was significantly (p<0.05) reduced compared to the healthy 
reference group; apparent as a 12% higher oxygen cost of walking at 4.5 km·h-1 at 5% 
inclination. This was accompanied by a concomitant significant (p<0.05) reduction of 
13% in walking efficiency. 
x  SUD patients had significantly (p<0.05) lower maximal muscle strength compared to 
the healthy reference group, exhibited as 30% and 33% lower group average 1RM in 
male and females, respectively. The reduced 1RM was accompanied by a tendency 
(p=0.09) towards reduced RFD (20%) in SUD males compared to male references. 
x  The reductions in aerobic endurance and muscular strength were consistently present 
in all age groups, with no significant differences observed between patients who had 
amphetamine or cannabis as their primary drug. Finally, VO2max correlated 
significantly with years of drug use; however, this correlation was not present when 
adjusted for age. 
 
Paper II 
x Male amphetamine users displayed lower whole body, total hip and femoral neck BMD 
of 8% (p<0.001), 10% (p<0.001) and 9% (p<0.05), respectively, compared to the 
healthy reference group. Female amphetamine patients showed significantly lower total 
hip and whole body BMD  of 11% (p<0.001) and 7% (p<0.05), respectively.  
x The male amphetamine users had significantly lower TBS (4%) at the lumbar spine 
compared to healthy controls, whilst female users tended (p=0.07) to have lower TBS 
(5%). 
x The male amphetamine users had a 48% (p<0.05) higher serum level of the bone 
formation marker P1NP compared to the reference group. P1NP tended to be higher 
(23%, p= 0.10) also in females.  
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x Male patients had a 30% significantly (p<0.001) lower 1RM compared to the reference 
group and a 27% significantly (p<0.01) lower RFD. Female patients displayed a 25% 
significantly (p<0.05) lower 1RM than the healthy reference group.  
Paper III 
x VO2max significantly (p<0.01) improved by 15 ± 7% for the 9 SUD subjects that 
completed the training intervention. The improvement was also significantly (p<0.01) 
different from the SUD control group receiving only conventional treatment. No 
within group improvement in VO2max was observed in the SUD control group 
following the 8 weeks period. 
x 9 of the 12 SUD patients completed the high aerobic intensity training. 1 participant 
dropped out from both the training study and the clinical treatment and 2 of the 
patients dropped out from the training only. 
x A significant (p<0.05) within group reduction in depression was seen in the high 
aerobic intensity training group 
 
Paper IV 
x MST in SUD patients significantly (p<0.01) improved hack squat 1RM by 88±54% 
and plantar flexion 1RM increased 26±20%. Hack squat RFD significantly (p<0.01) 
increased with 82±28%. No changes were observed in the SUD control group 
receiving only conventional treatment for any of the strength parameters. 
x 9 out of 12 SUD patients completed the MST. The 3 patients that dropped out from 
the strength training also dropped out of the clinical treatment at the same time. 
For the psychological variables, there were no between groups difference on level of anxiety 
and depression after the training intervention. Both groups displayed significant within groups 
reduction in anxiety level (p<0.05), while level of depression tended to decrease (p=0.11 for 
the MST group and p= 0.10 for the SUD control group). The insomnia score decreased 
significantly (p<0.05) in the MST group, which according to the ISI changed the insomnia 
level from the category of “subthreshold insomnia” to “no clinically significant insomnia”. 
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Results across papers 
x Female SUD patients with a low muscular strength had a significantly (p<0.05) higher 
anxiety level (12.0 ± 3.9) compared to female SUD patients with moderate strength 
(7.4 ± 4.8, Table 1). 
x Male SUD patients with a low muscular strength had a significantly (p<0.05) higher 
depression level 8.6 ± 4.0 compared to male SUD patients with moderate strength (6.2 
± 3.7, Table 1). 
 
Table 1. Psychological measurements and muscular strength level (one repetition maximum) 
 Male (n=49) Female (n=21)  
 Moderate 
strength 
Low strength Moderate 
strength 
Low strength 
     
Anxiety        (0-21) 9.6 ± 4.9 12.0 ± 3.9  7.4 ± 4.8 12.0 ± 3.7*  
 
Depression (0-21) 6.2 ± 3.7 8.6 ± 4.0* 4.7 ± 3.7 5.8 ± 2.2 
 
Insomnia     (0-28) 10.3 ± 7.3 13.5 ± 5.9 8.7 ± 5.8 11.1 ± 7.4 
Average hack squat 1RM for SUD is 121 kg and 70 kg for men and women respectively (Paper 1). Moderate 
strength: Male 1RM=≥120 kg, female 1RM≥70. Low strength: Male 1RM= <120 kg, female 1RM<70 kg. 
Anxiety and depression scores; 0-7: normal, 8-10: signs of anxiety/depression disorder, 11 or higher: probable 
presence of disorder. Insomnia scores; 0-7: normal, 8-14: threshold insomnia, 15-21: clinical insomnia 
(moderate severity), 22-28: clinical severity (severe). *p< 0.05. 
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DISCUSSION 
There is a high prevalence of cardiovascular disease, other life-style related diseases and 
premature death among SUD patients. This may be a direct consequence of their substance 
use, but may also indicate that they have a poor physical health. Since little is known, through 
direct assessment of physiological key factors, of this patient groups’ aerobic endurance, 
muscular strength and bone mass, we sought to evaluate if the patient groups’ physical health 
was indeed attenuated compared to what is typically observed in the healthy population. 
Furthermore, if the SUD patients had an impaired physical health, we sought to investigate if 
it would be feasible to implement effective physical training as a part of the clinical treatment, 
and if the patients would exhibit similar adaptations to training as what previously had been 
shown in healthy subjects and other patient groups. Finally, since synergistic effects have 
been shown between physical and mental health, we wanted to examine if an improvement in 
the patients’ physical health lead to an improvement also in their mental health. The main 
findings of this thesis’ four papers were that SUD patients had a reduced VO2max , walking 
efficiency, 1RM, RFD, and BMD compared to healthy. Furthermore, the SUD patients were 
able to improve these aerobic endurance and muscle strength components following training, 
to a level similar to what is observed in the healthy population. In contrast, somewhat 
surprisingly, the conventional SUD treatment did not lead to any alterations the patients’ 
physical health. Finally, the papers revealed indications that muscle strength and aerobic 
endurance status and improvement may have an effect on the patients’ anxiety, depression 
and insomnia. Combined, these results imply that effective aerobic endurance training and 
strength training should be implemented as part of clinical treatment. 
 
 
Reduced aerobic capacity among SUD patients 
VO2max measurements in paper I and III demonstrated that the SUD patients have a reduced 
aerobic capacity compared with healthy controls. The reductions are comparable to what is 
observed with ~20 years of aging (134, 135), and implies an increased risk of developing a 
wide range of lifestyle related diseases and early death (51, 53). Compared to the healthy 
controls these measures were 15% and 25% lower on average for male and female SUD 
patients, respectively. Our results are in line with observations on SUD methamphetamine 
patients (65), and SUD patients in a rehabilitation project (64) which both revealed even 
lower VO2max results than in our studies. There are some challenges comparing these studies 
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with regards to drug use severity in the SUD populations in each study, possible differences in 
test methods and protocols may explain some of this discrepancy. The criteria for reaching 
VO2max in the two studies referred to above are not precisely explained; and it is thereby 
difficult to decide if the same criteria were used for reaching VO2max. However, collectively, 
our results and the results from the studies by Dolezal et al. (65) and Mamen et al. (64) are in 
line showing an impaired aerobic endurance, and consequently an elevated risk of diseases 
and early death. 
 
 
Reduced muscular strength among SUD patients 
To our knowledge, this is the first time strength measurements among SUD patients have 
been compared with a healthy control group. Paper I, II and IV reports that the reductions in 
aerobic capacity were accompanied by a low force generating capacity. In paper I the SUD 
patients showed average reductions in hack squat 1RM of 30% (male) and 33% (female) 
compared to healthy controls. These reductions elevates the patients’ risk for falls and 
fractures (136), premature death (137, 138) and can be compared to 30-35 years of aging 
(139). Several studies have shown a relationship between maximal strength and RFD (59, 71, 
109, 114, 140, 141), which we also observed in our studies (paper I, II and IV). In paper I, 
RFD also showed a clear tendency to be 20% and 15% reduced in SUD males and females, 
respectively, compared to the healthy controls. 
 
RFD and its effect on walking economy and walking efficiency have previously been shown 
(124, 142). Indeed, also in this thesis, the reduced RFD observed in paper I was associated 
with reduced walking efficiency. These observations demonstrate that an attenuated muscular 
force development affects both the strength and endurance sides of the physical health 
spectrum. Combined, this may contribute to extra challenges performing physical work, and 
may lead the SUD patients in a downward spiral, where the reductions in physical capacity 
lead to reduced functionality and probably even more inactivity (60, 143). 
 
The patients’ physical capacity scores in paper I were not associated with type of primary 
drug, which implies that the chemical composition of the different drugs does not appear to 
influence physical capacity. This suggests that the reduced aerobic capacity and force 
generating capacity may be caused by an inactive lifestyle rather than the actual drug use. 
Taken together, a reduced 1RM and RFD will result in daily tasks being relatively heavier to 
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carry out for the SUD patients than for healthy individuals, adding weight to an already 
challenging situation. 
 
 
Bone health among SUD patients with amphetamine as primary drug  
A few previous studies have indicated that amphetamine use may lead to reduced bone quality 
and increased risk of osteoporosis (47, 48, 144), and an association between amphetamine use 
and reduced bone health has been reported (47, 48, 144). These studies build their evidence 
up on measurements of the calcaneus (47) and BMD in the lumbar spine (48). Paper II in the 
current thesis was the first to report evidence that amphetamine users have impaired bone 
health at several skeletal regions, along with reduced bone quality in the lumbar spine. Almost 
half of the patients in our study had a T-score within the classification osteopenia, meaning 
lower BMD than normal, but not to the extent of osteoporosis.  
 
Observations such as tooth decay and increased fracture rate among amphetamine users have 
led to the assumption that amphetamines have a negative effect on bone health. Although one 
study demonstrated that amphetamines might have a direct effect on bone metabolism (144) 
we cannot distinguish such an effect from the results in paper II. We found associations 
between bone quality and muscular strength in this study, which is in line with earlier studies 
on several different populations (145-147). In paper II we measured lower hack squat 1RM 
(30% in males and 25% in females) amongst amphetamine users than in healthy controls. 
Hack squat RFD was also reduced by 27% in the male amphetamine group. These findings 
expand the results from the SUD patients in paper I, and their association to an inactive 
lifestyle. It is likely that the reduced muscular function, possibly caused by inactivity, could 
be a mediator for the impaired bone health found in paper II. In paper I there were no 
differences on the physical capacity measurements observed between patients who had 
amphetamine or cannabis as their primary drug. Additionally, in paper II, the whole body 
scans revealed that the patients had a higher fat mass and less lean mass than the reference 
group. Low lean mass is usually caused by low levels of muscle activity (148, 149). It 
remains unclear which proportion of bone mass deterioration that may be caused by the 
amphetamine use, and which proportion that may be a result of inactivity. However, the 
results from paper I and paper II collectively suggest that lifestyle related alterations in 
muscle function may be an important factor contributing to impaired skeletal health. This 
topic should be addressed in future research.  
41 
 
Among the SUD patients with amphetamine as their primary drug and a history of extensive 
amphetamine use in paper II, impaired BMD and altered bone metabolism was observed. 
Despite the reduced bone mass, the serum levels of the bone formation marker P1NP was 
higher than both the healthy reference group and values typically expected among men and 
women at similar age. It is unlikely that this reflects an advantageous effect on bone turnover, 
and might therefore be a manifestation of a compensatory response (144). The bone 
resorption marker CTX did not differ between the groups. The amphetamine users in paper II 
showed relatively low levels of vitamin D, with serum 25-ODH level of 68 ± 24 (males) and 
63 ± 17 (females). Serum concentrations of 25-OHD at 75 nmol/liter or higher are considered 
as optimal and desirable (150, 151). There is no standard definition of vitamin D deficiency. 
According to the WHO (2003), a serum 25-ODH level below 50 nmol/liter is considered as 
vitamin D insufficiency (152). In patients with osteomalacia, low levels of vitamin D has been 
associated with increased level of P1NP (153, 154). However, since the level of vitamin D 
was not significantly lower in the amphetamine group than the reference group we cannot 
assume that this alone explains the increased level of the bone formation marker. 
 
 
Exercise training interventions in SUD patients 
Paper I and II documented that SUD patients had attenuated physical health, and their 
physical health may be interrelated with their mental health. Therefore, in paper III and IV, 
we used well-established aerobic endurance (88, 90, 91, 93) and strength training (66, 109, 
124, 155) interventions, respectively, to improve the SUD patients’ physical health. 
Specifically, high aerobic intensity interval training was used to improve the patients VO2max 
in paper III, whilst MST was applied to improve maximal muscle strength, RFD and walking 
efficiency in paper IV. Additionally, we used a battery of questionnaires to evaluate the effect 
on mental health variables. Importantly, since SUD patients certainly represent a challenging 
patient population, we also aimed to evaluate not only the patients’ physiological responses, 
but also the feasibility of the training interventions in a clinical setting. 
 
 
High aerobic intensity interval training in patients with SUD 
In paper III, 75% of the patients completed the training intervention. Although the applied 
intensity in the intervention in paper III may be somewhat strenuous, it is important to 
recognize that the intensity is not maximal. The high aerobic intensity training is organized to 
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specifically target the stroke volume of the heart. The four minutes intervals are selected as a 
middle way between the time necessary to reach a sufficient blood flow, and the time 
resulting in too much lactate accumulation. Due to sluggishness of the blood flow, it takes ~1-
2 minutes before a sufficient shear stress is placed on the heart (156). On the other hand, the 
upper end of the time spectrum is limited by the continuous lactate accumulation, resulting in 
about ~8 minutes as the maximal time at this given intensity (88). If several intervals are to be 
carried out, 4 minutes should be a simple and good strategy. The active rests at low intensity 
in the three minutes bouts between the high intensity intervals ensure the removal of lactate 
before the next 4 minute interval. Since the intervals are carried out walking or running uphill, 
they also place a very benign force on the joints, and thus represent a minimal risk for 
injuries. In accordance with this notion, no injuries or complications were reported in the 
current study.  
 
Following the interval training, SUD patients improved VO2max by 15 ± 7%, which is in 
accordance with improvements observed in healthy (88), elderly (157), cardiovascular disease 
patients (90, 93), metabolic syndrome patients (158) and schizophrenic patients (92). The 
magnitude of the improvement is dependent on the fitness level at baseline; for a higher 
VO2max starting point, a lower improvement should be expected (159). For several patient 
populations the baseline values are very low (160-162), like in paper III. The large 
improvements following training should thus be expected to yield substantial health benefits. 
The 6.5 ml·min-1·kg-1 improvement in VO2max in paper III may be associated as much as a 
~20% increase in survival and ~25% reduced chance of developing cardiovascular disease, as 
3.5 ml·min-1·kg-1 differences in VO2max previously have been associated with 12% improved 
chance of survival (51) and a 15% reduced risk of developing cardiovascular disease (53). In 
addition to likely having large health benefits, the improved aerobic capacity in paper III 
likely also resulted in improved performance during daily activities. An improved aerobic 
endurance could either yield the potential to carry out more work throughout the day, or may 
cause the daily tasks to be less strenuous since the relative intensity is lower compared to 
before training (160, 163, 164). Notably, the SUD patients in the control group receiving 
conventional treatment did not improve VO2max, despite of participating in the treatment 
clinics’ mandatory activity program. One plausible explanation for this result might have been 
that the activities were carried out with too low aerobic intensity, since aerobic intensity is 
considered to be the most important factor for VO2max improvements (88, 165).  
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Paper III demonstrated that SUD patients’ VO2max values can be restored to a level similar to 
an age-matched healthy population (166), and that the intervention was feasible in a clinical 
setting. Also the socioeconomic gain from these health improvements should be expected to 
be substantial, considering the reduced risk for this patient group to develop severe lifestyle 
diseases that acquire medical health care.  
 
Maximal strength training in SUD patients  
SUD patients exhibited large improvements in all strength measurements following the MST 
intervention in paper IV. Especially the improvement in 1RM was large (88 ± 54%) compared 
to other studies with the same training intervention (60, 109). However, the magnitude of 
improvement is likely exercise specific, and whereas most previous MST training studies (60, 
109) have used a horizontal leg press, a hack squat apparatus was used in paper IV in the 
current thesis. This makes it difficult to compare the magnitude of improvement between 
studies.  
 
The improvements in 1RM in paper IV were accompanied by large improvements in RFD (82 
± 28%). This is in accordance with previous studies (60, 107, 109), which also report similar 
improvements in RFD after 8 weeks of MST. The large improvements in 1RM and RFD 
without any alteration in body weight indicates that the strength gain is only minimally due to 
increased muscle mass, and may predominantly be caused by neural factors (107, 114).  
 
The V-wave method applied in paper IV is a useful technique for expressing efferent neural 
drive to maximally contracting skeletal muscles. The method utilizes modulations of the 
muscle spindle reflex of the soleus muscle (H-reflex). More specifically, it reflects the amount 
of reflex potentials recorded in the muscle during supramaximal electrical stimulation, and 
depends largely on the magnitude of voluntary efferent drive. To allow comparisons between 
and within groups, the V-wave is normalized to the maximal M-wave (V/M-ratio). The V-
wave potential origins from the reflex potential evoked during supramaximal electrical 
stimulation. While the amplitude of the V-wave is shown to increase following strength 
training (69, 167), the amplitude of the H-reflex is repeatedly reported to not change with 
strength training (167, 168). On this basis, any change in V-wave amplitude is argued to 
reflect a change in efferent drive, as it will allow more or less of the reflex to pass through to 
the muscle. Although the V/M-ratio cannot determine the influence from pre/post synaptic 
inhibition, it closely reflects any training-induced changes in efferent drive. In paper IV the 
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SUD patients exhibited large improvements in V/M-ratio (88%), suggesting that MST was 
indeed very effective in targeting neural adaptations. The improvements are in accordance 
with previous studies applying the V-wave method (169, 170), adding weight to the 
trainability of SUD-patients, also neurologically.  
Importantly, as a result of the MST intervention, the SUD patients achieved large 
improvements in force generating capacity, restoring the SUD patients 1RM and RFD to a 
level that is similar to what was observed in the healthy age matched population. As a 
consequence, we can expect that the risk for falls and fractures (136) and premature death 
(137, 138) was counteracted, and that balance and body control was improved (171). The 8 
week MST intervention was clearly very effective and feasible to carry out in the clinic. 
However, the large improvement in force generating capacity in untrained subjects is subject 
to detraining, especially in the functionally important concentric part of the muscular 
contractions (172). As this patient group may suffer a lack of initiative to continue exercising, 
clinical treatment should preferably offer a follow-up of the patients after their 3 month 
residence in the clinic. A follow-up training clinic may be a cost effective way to maintain, 
and even improve, the endurance and muscular strength capacities of the patient group. 
  
 
Compliance and dropout in the training studies 
One of the objectives in paper III and IV was to examine the feasibility of high intensity 
training in the clinic, and if the patient population were able to follow the two training 
regimes for eight weeks. In paper III, 9 out of 12 patients completed the high aerobic intensity 
endurance training. Two dropped out due to personal reasons, but completed their clinical 
treatment. One patient dropped out from the clinical treatment and thereby also from the 
training group. Whilst the two first drop outs may be ascribed to the training itself, the latter is 
difficult to determine if the reason is due to the clinical stay, the exercise training or other 
causes. However, a dropout rate of 2-3/10 has also been present in a healthy young population 
(88), indicating that this training modality and intensity is as feasible in SUD patients as in 
healthy subjects. Notably, the number dropping out from the SUD control group receiving 
conventional treatment was higher. Five patients, in contrast to one in the interval group, 
dropped out of the clinical treatment during the time of the intervention period. This certainly 
indicates that the high aerobic intensity endurance training is feasible, and may even be 
beneficial for completion of the clinical treatment. 
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As in paper III, 9 out of 12 patients completed the MST in paper IV. All 3 patients that 
dropped out from MST, also dropped out of clinical treatment. In combination, paper III and 
IV suggests that SUD patients indeed are capable of fairly strenuous endurance and strength 
training. Interestingly, 5 patients dropped out from the SUD control group also in paper IV.  
Although the number of participants in these two training study is relatively low, a ~67% 
higher dropout rate from the SUD control groups receiving conventional treatment is thought-
provoking. Given that the conventional treatment also had no effect on the SUD patients’ 
aerobic endurance or muscular strength, our results strongly suggests that the effective 
training in paper III and IV should be implemented as a part of clinical treatment. Since both 
high aerobic intensity endurance training and MST separately gave large improvements in 
different physiological key factors, we will argue that they should be carried out concurrently 
in a clinical treatment. Although it may be somewhat more challenging to do both the training 
modalities in one session, it is noteworthy that it takes less than one hour to complete a single 
concurrent training session. It is also possible that the patients may be more motivated by the 
“double effect”. This should be a topic for future evaluation. Previously it has been shown 
that concurrent high aerobic intensity endurance training and MST appears to have similar 
effects as when the respective interventions are carried out alone (117, 173). 
 
 
 Associations between physical and mental health 
In the current thesis, data on psychological variables were collected in paper I and II. Our 
results are in line with previous studies documenting that SUD, depression and anxiety are 
closely associated (78, 174, 175). The SUD patients scores in this thesis was “moderately 
severe insomnia” according to ISI and showed presence or signs of anxiety and depression on 
the HAD scale. Interestingly, when data from both cross sectional studies were combined we 
observed that female SUD patients with lower muscle strength than average had a higher 
anxiety level compared with female patients with higher muscle strength than average. 
Similarly, male SUD patients with lower strength than average had higher depression level 
than male patients with higher muscle strength than average. This association between muscle 
strength and anxiety and depression is in accordance with a cohort study by Ortega et al (55) 
where a large sample of 1 142 599 Swedish male adolescents, age 16-19 years, were followed 
over a 24 year period. In the Ortega et al. study (55) it was documented that muscular strength 
was associated with a psychiatric diagnosis as well as premature death (caused by diseases 
and suicide). Loss of muscular strength is shown to appear with aging, disease or inactivity. 
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Inactivity, which is proposed as a possible cause of the high risk of illness and early death 
among SUD patients earlier in this thesis, is in several studies also associated with mental 
illness (80, 176). 
 
 
Beneficial effects of physical health improvements on mental health  
Given the large improvements in aerobic endurance and muscular strength the SUD patients 
achieved in the two training interventions (paper III and IV), it was somehow unexpected that 
we were not able to detect between-group differences in the psychological variables between 
the SUD training groups and the SUD control groups. However, following the high aerobic 
intensity training (paper III) we did find reductions in depression level in the training group at 
posttest, but between-group differences on these two variables were not found. In paper IV 
both groups displayed reduced anxiety level after the MST intervention and the level of 
insomnia was decreased in the MST group, but again no between group differences were 
observed. There are several possible explanations for the lack of differences in the 
psychological variables in our studies. Firstly, the intervention studies have quite small 
sample sizes. Secondly, it is reasonable to question whether the self-report questionnaires 
used are appropriate tools for detecting the mental health benefits from a physical training 
intervention. A third possibility is that the improvements of the psychological variables within 
the groups were more related to the physical activity in general (both the training 
interventions and the physical activities in the conventional treatment), and not necessarily to 
the training interventions (79). There is a broad agreement that physical activity has a positive 
influence on mental health (79, 177, 178). However, the knowledge about physical capacities’ 
importance for mental health is scarce (177). A few studies have documented that improved 
aerobic endurance have beneficial effects on psychological outcomes as depression and 
anxiety (80, 179, 180). With the large improvements in physical capacity, and subsequent 
reduced risk of developing lifestyle diseases and early death, further investigation is needed to 
find possible effects on mental health. 
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Future perspective 
Although all patients were diagnosed within the same diagnostic criteria system (ICD-10) for 
SUD, it might be a limitation that all patients in this thesis were recruited from the same 
treatment clinic. Thus, it would be beneficial in future research if our results were confirmed 
from other clinics as treatment programs may be different. Furthermore, although the sample 
size in our studies was sufficient with regards to the main physiological variables and 
hypothesis, the mental variables, assessed by questionnaires, would likely have benefitted 
from a larger sample size. Nevertheless, the observations in the four papers in this thesis 
suggest that exercise should be an essential part of clinical treatment programs. If carried out 
in accordance with procedures described in papers III and IV, exercise will likely give 
substantial health and performance benefits, reduce the risk of developing comorbid diseases 
in addition to the SUD, reduce socioeconomic costs and perhaps improve mental health. 
Although physical activity is not novel in SUD treatment, the activities seem random and 
unstructured and typically involve only low to moderate intensity exercise with regards to 
both endurance and strength. Paper III and IV documented no improvements in VO2max or 
muscular strength in the SUD control groups after eight weeks in treatment, despite a wide 
activity program included in the weekly treatment program. Approximately one hour, four 
days a week, was set aside for activities like yoga, stretching and low resistance strength 
training. In this thesis we have shown how it is feasible to obtain substantial improvements 
from high aerobic intensity interval training and MST in this population within eight weeks, 
and that it is feasible both among the SUD patients and within the clinical frame. Thus, this 
should also be advocated as a part of a standard future clinical treatment. 
 
Implementing effective physical training in the clinical treatment program certainly had its 
challenges. Completing these projects was rewarding and demanding in several ways. 
Although supervising, training and testing were time consuming, it was typically easy to 
collaborate with the patients and they were appreciative of the training. In contrast, somewhat 
surprisingly, although the studies were supported by the clinic, it was difficult to administer 
and coordinate the logistics revolving around the patients’ training with the employees in the 
clinic. This may represent a challenge for implementing the effective training in similar 
clinics in the future, and detailed explanation of the purpose and potential effect of the 
training should be emphasized. The papers in this thesis clearly documents that not only is it 
feasible, the SUD patients also appear to appreciate the initiative, and it does not interfere 
with their daily routines. The patients also reported that they liked the challenge that the 
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training and testing amounted. Finally, a question that should be posed is why should we have 
lower expectations to SUD patients to care about own health and capability of completing a 
training intervention than other patient populations? When recruiting patients to the project, 
we were clear about the expectations from them as participants, and that the expectations were 
the same as from other populations. This seemed to motivate them for committing to the 
project. We recognize that these are only non-documented observations from the researchers, 
but it may still be an important notion if the aim is to implement effective training in clinics. 
Systematic information to, and support from, all employees in the clinic may facilitate the 
training implementation. 
 
 
CONCLUSION 
SUD patients exhibited a systematically attenuated physical health compared to what is 
typically observed in the healthy population. Specifically, this was evident as a reduced 
VO2max, walking efficiency, 1RM, RFD and BMD. These reductions imply that the patient 
group suffers a higher risk of developing cardiovascular disease, other lifestyle diseases and 
early death compared to the healthy population. The aerobic endurance and muscular strength 
impairments were systematically present regardless kind of primary drug, which indicate that 
the reductions may rather be caused by an inactive lifestyle than the direct effects of the 
various drugs. In contrast, high aerobic intensity interval training- and MST restored the SUD 
patients’ physical health to a level similar to what is observed in the healthy population. 
Although challenging, the training interventions were feasible in the clinic, with a low drop-
out rate. In combination, our results suggest that the training interventions carried out in this 
thesis should be advocated as a part of SUD treatment programs. This may not only have 
beneficial effects on the SUD patient’s physical and mental health, but may also reduce 
socioeconomic costs. 
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Paper I
Impaired Aerobic Endurance and Muscular Strength in
Substance Use Disorder Patients
Implications for Health and Premature Death
Grete Flemmen, MSc and Eivind Wang, PhD
Abstract: Although substance use disorder (SUD) patients are docu-
mented to have an inactive lifestyle, which is associated with cardio-
vascular disease, other lifestyle-related diseases and premature death,
evidence regarding their aerobic endurance and muscular strength is
limited. Therefore, the authors aimed to evaluate directly assessed
maximal oxygen consumption, walking efﬁciency, as well as maximal
strength in a group of SUD patients.
A total of 44 SUD patients in residential treatment, 31 men (31 8
years) and 13 women (34 10 years), were included and completed the
physical testing. The patients were compared with an age- and sex-
matched reference group.
Male and female SUD patients exhibited a maximal oxygen con-
sumption of 44.6 6.2 and 33.8 6.6mL min1 kg1, respectively.
This was signiﬁcantly lower than the reference group, 15% (P¼ 0.03)
for men and 25% (P¼ 0.001) for women. In addition, the SUD patients
had a 13% signiﬁcantly reduced walking efﬁciency (P¼ 0.02), com-
pared with healthy controls. The impairments in aerobic endurance were
accompanied by signiﬁcant reductions in maximal strength of 30%
(P¼ 0.001) and 33% (P¼ 0.01) for men and women, respectively. In
combination, these results imply that SUD patients have impaired
endurance and muscular strength compared with what is typically
observed in the population, and consequently suffer a higher risk of
developing cardiovascular and other lifestyle-related diseases and early
death. Effective physical exercise should be advocated as an essential
part of the clinical practice of SUD treatment to improve the patient’s
health and consequently reduce the costs because of the high use of
emergency departments, hospital, and medical care.
(Medicine 94(44):e1914)
Abbreviations: HRmax = maximal heart rate, ICD-10 =
International Classiﬁcation of Diseases rev 10, [La-]b = lactate
concentration in blood, MET = maximal metabolic equivalent,
1RM = one repetition maximum, Q = cardiac output, RER =
respiratory exchange ratio, RFD = rate of force development,
SUD = substance use disorder, VE = ventilation, VO2max = maximal
oxygen consumption.
INTRODUCTION
P atients with substance use disorder (SUD), classified withinInternational Classification of Diseases rev 10; F10–19
(World Health Organization’s classification 1990) have in
addition to their mental and behavioral disorders an increased
prevalence of cardiovascular disease,1 cancer,1 attenuated bone
health,2 and a decreased life expectancy of 15 to 20 years,
the lowest among patients with different mental illnesses.3
Undoubtedly, various causes contribute to the mental as well
as physical problems that substance users suffer.3 Evidence,
however, is limited regarding the patient groups’ physical
health status and its likely influence on their overall health
problems, cardiovascular system, and muscle strength and
function, especially through direct assessment of key factors,
such as maximal oxygen consumption (VO2max), walking
efficiency, maximal strength, and muscle force development
characteristics.
VO2max, commonly also referred to as cardiorespiratory
fitness and given in maximal metabolic equivalents (METs), is
one of the strongest predictors for mortality from cardiovascular
disease and other causes.4–6 Analyzing several risk factors, Wei
et al4 observed that a low VO2max resulted in a similar, if not
greater, relative risk of mortality compared with established risk
factors, such as diabetes mellitus, high cholesterol levels,
hypertension, and cigarette smoking. The relative risk of
mortality has been quantified from estimated VO2max showing
that a reduction of 1MET (3.5mLmin1 kg1) corresponded
to a 12% increase in mortality.5 More recently, this was
confirmed by Kodama et al6 who observed a decrease of 1
MET to be associated with a 13% to 15% higher risk of all-cause
mortality and coronary heart disease.
Not only VO2max, but also skeletal muscle strength has
been increasingly recognized as a considerable risk factor for
mortality,7,8 cardiovascular disease,8 and cancer.7 The mortality
risk from impaired muscle strength is comparable with the
elevated risk from hypertension and obesity.8 Reduced muscle
strength is also shown to result in poor bone health9 and an
absence of sufficient muscular overload, through lack of
physical activity or resistance training, will consequently
induce bone loss.10 Thus, the synergetic effect between mus-
cular strength and VO2max should be emphasized in clinical
practice as prevention and treatment of cardiovascular disease
as they in combination represent a substantial risk reduction.11
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Importantly, both a reduced VO2max and low muscular
strength are also shown to be associated with a poor mental
health.8,12 VO2max is in several studies associated with diag-
nosis of psychosis or schizophrenia,13,14 and a low muscular
strength is associated with a 20% to 30% increase in suicide rate
in young adults.8 The number of suicides in SUD patients may
be even higher than in the general young population as a
significant part of deaths are because of drug overdose,1,3
and it is difficult to determine if this is because of accidents
or suicide. Although causality is difficult to interpret from these
findings, a low physical fitness typically leads to loss of daily
functions, which in turn are associated with depressive symp-
toms. In contrast, physical activity is documented to be an
effective countermeasure.15
Although documentation of SUD patients’ physical health,
through direct assessment of VO2max and muscular strength is
limited, a few studies are indicating that the patient group is
indeed at risk. Recent research has evaluated the effects of
aerobic endurance training and shown that SUD patients had a
20% lower VO2max than what is typically seen in the popu-
lation.16 Our results were in line with observations from meth-
amphetamine dependents, revealing severely reduced VO2max
values,17 and SUD patients in a rehabilitation project, which
displayed values of 39 10 (men) and 31 8 (women)
mL min1 kg1 in 30-year-old patients.18 Although it lacks
a comparison with healthy individuals, one recent study17
documented that SUD patients’ reduced VO2max may be accom-
panied by reductions in maximal muscle strength with reported
values as low as 60 kg in leg press and 40 kg in chest press.
It, however, is difficult to interpret these findings because joint
angle are not reported and apparatus construction is not known,
and these factors are clearly relevant for comparison with other
populations. Despite that, muscular strength reductions often
accompany inactivity-related reductions in VO2max; this is to
our knowledge the only study that has indicated that SUD
patients may have an impaired muscular strength.
Although a few studies imply that SUD patients may be at
risk for cardiovascular disease, other lifestyle-related diseases
and premature death because of their reduced cardiorespiratory
and muscular fitness, there is a clear need for a more robust
assessment of the SUD patients’ physical health across sex, age,
and primary drug dependence. Therefore, the aim of this study
was to directly assess the patients’ muscular strength as well as
aerobic endurance. Specifically, our hypothesis was that SUD
patients had a significantly reduced VO2max, walking effi-
ciency, maximal muscle strength, and muscle rate of force
development (RFD) compared with an age- and sex-matched
control group.
METHODS
Patients
We included 44 patients, 13 women (age 34 10 years;
weight 80.0 20.3 kg; and height 165 6 cm) and 31 males
(age 31 8 years; weight 85.1 15.9 kg; and height
181 7 cm), with a diagnosis of SUD; International Classifi-
cation of Diseases rev 10: F10–F19 (mental and behavioral
disorders because of psychoactive substance use). Twenty-two
of the men and 9 of the women were current smokers, respect-
ively. Patients’ medical use is given in Table 1. Patients were all
in a 3 months’ full-time residential treatment program. All
patients agreed voluntarily to participate in the study and signed
a written informed consent. Patients were excluded if they had
been abstinent from drugs for the last 6 months or if they had
impairments or injuries that prevented them from completing
the treadmill and/or strength tests. All patients who fulfilled the
inclusion criteria who arrived in the treatment clinic in a
6 months period were included in the study. The patients’
physical performance was compared with a healthy age- and
sex-matched reference group, targeted to exhibit what is typi-
cally observed in the population, consisting of 14 women (age
34 8 years; weight 68.8 7.9 kg; and height 171 5 cm) and
11 men (age 37 9 years; weight 89.3 10.9 kg; and height
183 6 cm), recruited among students and employees at the
local University Hospital. A total of 20% of the controls (one
of the men and 4 of the women, respectively) were current
smokers. The regional medical ethics committee approved the
study and it was carried out in accordance with the Helsinki
Declaration.
Testing Procedures
Maximal Oxygen Consumption and Walking
Efﬁciency
After a warm-up period of 10 minutes, patients started
the 5 minutes walking efficiency test at 5% inclination
and 4.5 kmh1. Oxygen consumption was obtained every
10 seconds (Metamax II Cortex Biophysik GmbH, Leipzig,
TABLE 1. Substance Use Disorder Patients’ Drug Use and
Prescribed Medicine
Man
(n¼ 31)
Woman
(n¼ 13)
Primary Drug
Heroin 2 —
Benzodiazepines, Sed, hypnotic 1 1
Amphetamine 20 10
Cannabis 8 2
Secondary Drug
Alcohol 1 3
Heroin 5 1
Opiates, painkillers 4 —
Cocaine 2 —
Amphetamine 4 1
Cannabis 14 8
Hallucinogens 1 —
Prescribed Medicines for Symptoms
Attention deﬁcit hyperactivity disorder 3 2
Allergies 4 4
Anxiety 4 2
Arthritis 4 1
Asthma/chronic obstructive
pulmonary disease
4 2
Depression 5 2
Epilepsy 6 1
Hypertension 3 1
Infections 1 3
Schizophrenia/bipolar 9 5
Skin disorder 2 2
Substitutional treatment 4 2
Other 8 3
Data are presented as meanSD. Prescribed medicines in substitu-
tional treatment are methadone and suboxone. Other prescribed medi-
cines: skin disorder, pain, and inﬂammation. Sed¼ sedatives.
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Germany), and net walking efficiency was calculated as an
average of the last minute as
Net waliking efficiency ¼ External work accomplished ðKcalmin
1Þ
Energy expenditure ðKcalmin1Þ 100
where oxygen consumption and work both were expressed as
kcal to express walking percentage efficiency.19 Continuously
from the walking efficiency test, the patients progressed to the
VO2max test, which consisted of an incremental ramped protocol
till exhaustion, where velocity was increased by 1 kmh1 every
minute and inclination kept constant at 5%. Maximal oxygen
consumption was calculated as an average of the highest 30-
second window. Pulmonary ventilation and respiratory
exchange ratio were averaged in the same period as the VO2max.
Criteria for reaching VO2max were used in accordance with
previous literature.20 Heart rate measurements were obtained
using heart rate monitors (Polar Electro, Finland), and maximal
heart rate was estimated as 3 to 5 beatsmin1 added to the
highest heart rate during the last minute.20 After completion of
the VO2max test, a fingertip blood sample was taken for
measurements of lactate concentration in blood (Biosen C_line,
EKF Diagnostics GmbH, Barleben, Germany).
Maximal Strength and Rate of Force Development
Measurements
After 2warm-up sets, one repetitionmaximum (1RM)was
performed in a hack squat machine (Impulse Fitness IT7006,
Shandong, China). The patients started in a standing position
and then moved eccentrically down to a 90o knee angle
position. After a fraction of a second stop, the patient then
moved concentrically with a fast intended velocity. The correct
knee angle position was assessed with a goniometer. The
load was increased with increments of 10 kg, and 1RM was
achieved within 4 to 8 lifts. The patients had rest periods of 4
minutes between their attempts. After completion of the 1RM
test, RFD was measured using a force plate (9286AA, Kistler,
Switzerland) in the same apparatus with a weight correspond-
ing to 75% of 1RM. Measurements were obtained with a
2000 Hz frequency (Bioware v3.06b, Kistler, Switzerland).
As for the 1RM test, the patients were instructed to try and
lift the weight as fast as possible in the concentric movement.
The highest RFD among 3 attempts was used for the data
analysis, and patients had 3 minutes rest periods between
their attempts.
Statistical Analysis
Statistical analyses were performed using the SPSS, ver-
sion 20, software program (Chicago, IL), and figures were made
using the software GraphPad Prism 5 (San Diego, CA). Inde-
pendent samples t test were used to compare differences
between the SUD patient group and the reference group.
Correlations between primary substance use, sex, age, sub-
stance use history, and physical capacity were analyzed using
linear Pearson correlation regression analysis. Results were
considered statistically significant at a 2-tailed level of
P< 0.05. Data are presented as meanSD unless otherwise
stated.
RESULTS
All 44 SUD patients [21–30 years (n¼ 23); 31–40 years
(n¼ 14); and 41–50 years (n¼ 7)] in residential treatment and
the 25 control age- and sex-matched patients [21–30 years
(n¼ 10); 31–40 years (n¼ 7); and 41–50 years (n¼ 8)] com-
pleted the VO2max test, walking efficiency test, and strength
tests. No differences were observed in body mass between the
2 groups, but female SUD patients tended (P¼0.08) to be
heavier than the controls.
Aerobic Endurance
Maximal oxygen consumption was significantly lower in
SUD patients compared with the reference group (Table 2), this
was apparent for both sexes (Fig. 1A). Women and men
displayed reductions of 25% (P¼ 0.001) and 15% (P¼ 0.03),
respectively. The lower aerobic power was consistently present
in all age groups (Fig. 1B). No significant differences were
observed between patients who had amphetamine (n¼ 30) or
cannabis (n¼ 10) as their primary drug (Fig. 2). Maximal
oxygen consumption correlated significantly with years of drug
use; however, this correlation was not present when it was
adjusted for age.
As for the maximal aerobic power, the SUD patients’
aerobic endurance at a submaximal level below anaerobic
threshold was also impaired. No differences were observed
between women and men in walking efficiency and as a con-
sequence, data were collapsed (Table 3; Fig. 3). The impairment
was apparent as a 12% (P¼0.05) higher oxygen cost of
walking at 4.5 km/h at 5% inclination (Fig. 3A), and this was
mirrored by a 13% (P¼ 0.02) reduction in walking efficiency
(Fig. 3B). This was further accompanied by a significant
increase in ventilation (P¼ 0.042) and respiratory exchange
TABLE 2. Physiological Variables Measured During a Maximal Oxygen Uptake Test
SUD Patients (n¼ 44) Reference Group (n¼ 25)
Male (n¼ 31) Female (n¼ 13) Male (n¼ 11) Female (n¼ 13)
VO2max, Lmin1 3.74 0.62 2.60 0.35 4.56 0.44 3.10 0.31
VE, Lmin1 113.6 19.5 77.4 13.7 131.5 17.5 95.9 11.5
RER 1.15 0.07 1.13 0.07 1.13 0.04 1.11 0.03
HRmax, beatmin1 185 10 181 13 192 11 190 10
[La-]b, mM 9.98 2.8 7.37 2.12 12.03 3.23 8.82 1.31
Data are presented as meanSD. HRmax¼maximal heart rate, [La-]b¼ lactate concentration in blood, RER¼ respiratory exchange ratio,
SUD¼ substance use disorder; VE¼ ventilation, VO2max¼maximal oxygen uptake.
P< 0.05.
P< 0.01. Signiﬁcant differences between patient group and reference group.
Medicine  Volume 94, Number 44, November 2015 Substance Use Disorder and Physical Health
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved. www.md-journal.com | 3
ratio (P¼ 0.001) among the SUD patients. Systematically, the
impairments were exhibited in both women and men and across
age.
Muscular Strength
Substance use disorder patients had a significantly lower
maximal muscle strength compared with the reference group,
with 1RM reductions of 30% (P¼ 0.001) and 33% (P¼ 0.010)
in men and women, respectively (Fig. 4A). A significant
r¼ 0.36 correlation between 1RM and RFD was observed
(y¼ 4.0xþ 874; 95% confidence interval: 1.4–6.5 and 555–
1193; P< 0.01), and the reductions in 1RM were accompanied
by a clear tendency toward a reduced RFD (Fig. 4B), expressing
20% and 15% reductions in men and women, respectively,
compared with healthy controls. Because an association
between muscular strength and walking efficiency, has been
established previously, the strength parameters and walking
efficiency were tested against each other, revealing that the
RFD significantly correlated (r¼ 0.38) with walking efficiency
(y¼ 0.0037xþ 17.9; 95% confidence interval: 0.0013–0.0062
and 14.3–21.4; P< 0.01), whereas 1RM did not. Furthermore,
the differences in maximal strength and RFD between SUD
patients and the reference group were consistently present for all
age groups, but were not affected by the drug type dependency.
DISCUSSION
Because VO2max and muscular strength are strong predic-
tors for physical and mental health, but evidence of directly
assessed aerobic endurance and strength components rarely has
been presented, our aim was to present such components and
evaluate their implications for health in SUD patients. The main
findings of the current study were that SUD patients have a
reduced VO2max compared with what is typically observed in
the population; aerobic endurance is further reduced because
of reductions in walking efficiency; the aerobic endurance
impairments were accompanied by reduced maximal strength
and ability to perform rapid muscle contractions; and the
FIGURE 1. A, Substance use disorder patients’ maximal oxygen
consumption were compared with the reference group, both
sexes and combined. Data are presented as mean SE.
Signiﬁcant difference between the reference group and SUD
patients (P<0.01). B, Maximal oxygen consumption, comparing
SUD patients and reference group, all age groups. Data are
presented as mean SE. Signiﬁcant difference between the
groups (P<0.05). SUD¼ substance use disorder.
FIGURE 2. Maximal oxygen consumption in patients with
amphetamine or cannabis as their primary drug, was compared
with reference group. Data are presented as mean SE.
Signiﬁcant difference between the groups (P<0.05). No signiﬁ-
cant differences between the 2 drug categories.
TABLE 3. Walking Economy at 4.5 km/h, 5% Inclination on a
Treadmill
SUD Patients
(n¼ 44)
Reference Group
(n¼ 25)
VO2, mLmin1kg1 19.1 1.6 18.0 1.6
VE, Lmin1 36.4 7.6 32.2 6.5
RER 0.91 0.04 0.87 0.04
%HRmax 64 8 61 8
Data are presented as meanSD. %HRmax¼ percentage of maximal
heart rate, RER¼ respiratory exchange ratio, SUD¼ substance use
disorder, VE¼ ventilation, VO2¼ oxygen uptake.
P< 0.05.
P< 0.01. Signiﬁcant differences between patient group and refer-
ence group.
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impairments in aerobic endurance and muscular strength were
systematically present across age, sex, primary drug, and history
of substance use. In combination, these findings imply that SUD
patients indeed are at risk for developing cardiovascular dis-
ease, cancer, attenuated bone health, and premature death, and
that inactivity may be responsible, at least in part, for the
physical health reductions.
Maximal Oxygen Consumption and Substance
Use Disorder
Substance use disorder patients in the current study exhib-
ited a systematically reduced VO2max compared with healthy
controls. The values of the patients in this study are also below
what recently was reported as reference data for the Norwegian
population.21 Specifically, the women in our study showed a
large attenuation in aerobic power, equivalent to what is
observed with 25 years of aging,22 and associated with a
25% increased risk of mortality.5,6 The reduction in VO2max
was not related to the patients’ drug type dependency (Fig. 2),
and was present for all age groups (Fig. 1B). Although well
below what is typically observed in the population, our VO2max
results are somewhat higher than previous studies that have
observed values of 39 (men) and 31 (women) mL min1
kg1,18 32 (indirectly estimated for men and women combined)
mL min1 kg1,23 and 31 (men) and 23 (women) mL min1
kg1.17 The discrepancy between these results may be because
of the different populations tested, indirect or direct measure-
ments of oxygen uptake, testing modality (i.e., bicycle or
treadmill), and protocol. In combination, our study and previous
studies are in agreement, observing that SUD patients, however,
have a reduced VO2max, and thus have an elevated risk for
cardiovascular disease, other lifestyle-related diseases and pre-
mature death. Alterations in VO2max is suggested to primarily be
caused by changes in cardiac output and function,24 and a
causality has been shown both with training25 and detraining.26
This implies that the very low VO2max that is observed in SUD
patients is likely accompanied by a severely reduced cardiac
output, and that this may be one of the factors that can explain
the high prevalence of cardiovascular disease within the patient
group.
FIGURE 3. A, Oxygen cost of walking at 4.5 kmh1 at 5%
inclination on the treadmill, comparing reference group with
substance use disorder patients. Data are presented as meanSE.
Signiﬁcant difference between the groups (P<0.05). B, Walking
efﬁciency at 4.5 km/h at 5% inclination on the treadmill, compar-
ing reference groupwith substance use disorder patients. Data are
presented as meanSE. Signiﬁcant difference between the
groups (P<0.05).
FIGURE 4. A, Muscular strength (one repetition maximum) in
substance use disorder patients and reference group. Data are
presented as meanSE. Signiﬁcant difference between the
groups (P<0.05) and

(P<0.01). B, Rate of force development
in substance use disorder patients and reference group. Data are
presented as mean SE.
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Walking Efﬁciency
Contributing to an overall reduced aerobic endurance in
SUD patients in the current study was also a reduction in
walking efficiency. Walking efficiency is approximately 25%
in healthy individuals,27 and our observation of 26% among the
healthy controls was in line with this. In contrast, the SUD
patients exhibited a 13% lower efficiency, meaning that not
only do they have to work on a higher percentage of their
VO2max when carrying out daily tasks, but they also have to do
the certain amount of work with a larger cost of energy
compared with healthy individuals. This is adding weight to
an already challenging situation and certainly contributes to the
negative spiral toward even more inactivity, and an aggravation
of the calamitous lifestyle. The decreased walking efficiency
has to our knowledge not been documented in SUD patients
before, and was present for both men and women in all age
groups (Fig. 3). Thought provoking, their walking efficiency is
similar to an efficiency that is observed among 50-year-old men
and women.28 Again, as for the VO2max measurements, the
reduced efficiency was not associated with the substance use
history or drug type dependency, and advocates that the SUD
patients’ lifestyle, and absence of sufficient activity, may be the
explanation for their weakened aerobic energy production.
Maximal Muscle Strength, Force Development
Characteristics and Substance Use Disorder
Patients
In addition to endurance, skeletal muscle strength is import-
ant for the assessment of an individuals’ physical health. The
current study show that SUD patients exhibited significant
maximal strength reductions compared with the healthy controls.
Although strength training has previously been applied on SUD
patients in residential treatment,17 it has, to our knowledge, not
been known how their strength relates to what is observed in
healthy patients. The 33% (men) and 30% (man) reduced strength
in SUDpatients in our study corresponds towhat is observedwith
30 to 40 years of aging,29 and puts the patients at an elevated risk
for falls and fractures,30 premature death,8,31 and possibly can-
cer.31 Importantly, reductions in maximal strength are usually
accompanied by reductions inmuscle RFD.19,32 Therefore, it was
not surprising that in the current study, RFD was correlated with
1RM. Rate of force development may be an evenmore important
predictor for physical function30 compared with maximal
strength because it is more related to functional tasks, balance
adjustments, and prevention of falls, where the time to reach
maximal strength is limited. The 15% to 20% lower RFD among
the SUDpatients in this studymay contribute tomore challenging
everyday situations and risk of injuries.
A relationship between muscular strength and aerobic
endurance has also been established, specifically through the
effects of RFD on aerobic work and walking efficiency.33,34 It is
suggested that alterations in RFD will lead to changes in the
force–velocity curve,33 resulting in changes in oxygen demand
in the working muscle, and consequently changes in blood
flow.34 Indeed, a correlation between RFD and walking effi-
ciency was documented in this study, and it is likely that a poor
RFD in the SUD patients have resulted in a worsening of their
aerobic endurance in accordance with previous literature.19,32
Physical Health in Substance Use Disorder
Patients: Implications for Mental Health
Previously, both VO2max and muscular strength have been
observed to be predictors for mental health.8,12 A weakened
aerobic endurance has been associated with depression12 and
psychosis,13 whereas muscular strength have been associated
with psychiatric diagnoses and even suicide.8 Although it is
often difficult to establish a cause–effect relationship, it has
been demonstrated that aerobic endurance training can decrease
depression.16 Enhanced physical health may lead to an
improved mental health because of changes in the individual’s
perception of physical as well as social factors. Because SUD
patients in the current study display large reductions in both
endurance and muscular capacity and function, it is likely that
this is associated with their mental health. It is an interesting
topic of future research if effective physical training may be
able to improve their mental state, and thus ultimately also have
an effect on their substance use.
Reduced Physical Health in Substance Use
Disorder Patients: Clinical Treatment
Perspectives
Although the sample size in the current study is relatively
small, our results indicate that SUD patients have a reduced
aerobic endurance andmuscular strength, consequently putting
them at risk for diseases, premature death, and an aggravation
of their mental health. The SUD patients’ attenuated physical
health likely has multifactorial causes. Drug use and cigarette
smoking may directly have contributed to the reduced physical
health observed in the current study. Indeed, especially
cigarette smoking is well documented to effect cardiorespira-
tory function and consequently reduce exercise capacity35,36 as
well as increase the risk of cardiorespiratory diseases.37 In
addition, the patient groups’ inactivity-related lifestyle may
indirectly have affected their aerobic endurance and muscular
strength as the lack of activity previously has been shown to
dramatically reduce both aerobic endurance26 and muscular
strength.38 Exercise training is shown to work as an effective
countermeasure for reduced endurance and strength, and
should be emphasized as a part of the clinical treatment.
Although today’s treatment of SUD patients commonly
includes physical activity, it appears random and unstructured,
without the sufficient training intensity to have a robust
effect.16 Importantly, high intensity is favorable to yield the
most optimal effects both for endurance25 and muscular
strength,39 and documented to be feasible and effective also
for untrained patient populations.16,32 Therefore, as one
element to counteract the SUD patients from spiraling down
the physical and mental cascade toward more inactivity and
substance dependence, effective training for improving aero-
bic endurance, muscular strength, and function should be
applied in the clinics, preferably targeting the optimal exercise
intensity and modality.
CONCLUSIONS
Applying direct assessment of physiological variables, our
findings show that SUD patients have a reduced VO2max,
walking efficiency, maximal strength, and ability to rapid force
development compared with healthy individuals. Because
reductions in these physiological factors are associated with
an elevated risk of cardiovascular disease, cancer, poor bone
quality, premature death, and mental health, effective exercise
training should be a part of the clinical treatment of the patient
group. This may not only have a beneficial effect on the
patients’ physical and mental health, but could also reduce
socioeconomic costs.
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Patients with substance use disorder (SUD) suffer a higher risk of cardiovascular disease and other lifestyle diseases compared to
the general population. High intensity training has been shown to effectively reduce this risk, and therefore we aimed to examine
the feasibility and effect of such training in SUD patients in clinical treatment in the present study. 17 males and 7 females (32 ± 8 yr)
in treatment were randomized to either a training group (TG), treadmill interval training in 4 × 4 minutes at 90–95% of maximal
heart rate, 3 days a week for 8 weeks, or a conventional rehabilitation control group (CG). Baseline values for both groups combined
at inclusion were 44 ± 8 (males) and 34 ± 9 (females)mL ⋅min−1⋅ kg−1, respectively. 9/12 and 7/12 patients completed the TG and
CG, respectively. Only the TG significantly improved (15 ± 7%) their maximal oxygen consumption (VO2max), from 42.3 ± 7.2mL ⋅
min−1⋅ kg−1 at pretest to 48.7 ± 9.2mL ⋅min−1⋅ kg−1 at posttest. No between-group differences were observed in work economy, and
level of insomnia (ISI) or anxiety and depression (HAD), but a significant within-group improvement in depression was apparent
for the TG. High intensity training was feasible for SUD patients in treatment. This training form should be implemented as a part
of the rehabilitation since it, in contrast to the conventional treatment, represents a risk reduction for cardiovascular disease and
premature death.
1. Introduction
Patients with substance use disorder (SUD), classified within
ICD-10: F10-19 (mental and behavioral disorders due to psy-
choactive substance use) at the World Health Organization’s
mental and behavioral disorders classification, have a high
prevalence of health and psychosocial problems in addition
to their substance use disorder [1]. Although this patient
group’s disorder indeed has multifactorial causes, the evi-
dence of how their physical capacity may be related to their
calamitous lifestyle is sparse. Contributing to a decreased life
expectancy of 15–20 years, the lowest among patients with
different mental illnesses [2, 3] is an increased prevalence of
cardiovascular disease [4–6].The high risk of developing car-
diovascular disease is associated with the population’s drug
use, poor nutrition, and obesity but is also likely a direct result
of the patient group’s inactivity [3].
Endurance training, especially with emphasis on high
intensity, is shown to increase aerobic power and reduce
the risk of cardiovascular disease [7–10]. Improvements of
10–30% in maximal oxygen consumption (VO2max) have
typically been observed in these studies, after training inter-
ventions of 2-3 months. These improvements may also be
associated with large reductions in the risk of mortality, as
an improvement of 1MET (∼3.5mL ⋅min−1 ⋅kg−1) is shown to
reduce the mortality rate by 12% [11]. Adding to the physical
benefits of exercise are also possible effects on mental health.
Although little is known about the effects of high-intensity
interval training in SUD patients, exercise has been docu-
mented to have an overall beneficial effect on mental health
and quality of life in patients with mental illnesses [12].
Despite the well-documented effect on cardiovascular
disease risk reduction [7, 8, 10], decreased mortality rate
[11, 13, 14], and improved mental health [15–19], effective
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57 SUD patients in the clinic at the time of 
inclusion
33 patients were not included:
28 patients were not asked to participate because they would 
leave the clinic before the end of the study
3 patients declined to participate
2 patients had injuries that excluded participation
24 patients were randomized into two groups
12 patients in the training group (TG) 12 patients in the control group (CG)
3 patients dropped out of the study:
2 withdrew due to personal reasons but completed their stay  
in the clinic
1 dropped out of both the clinical treatment and the study.  
Reason unknown
Reason unknown
5 patients dropped out of both the clinical treatment and from
the study. 
9 patients completed the training intervention 7 patients completed the conventional treatment
Figure 1: Recruitment, randomization, and withdrawal of SUD patients throughout the study.
physical training appears not to be a part of the conventional
treatment for SUD patients.There has certainly been physical
activities in the clinics for more than 30 years [20], but
in general this activity seems random and unstructured
and the frequency and intensity of the activities are often
unknown. Indeed the activities may vary between clinics, but
to our knowledge, it has not been documented that whole
body exercise with a high intensity (≥85% of HRmax) consti-
tutes a part of the clinical program. As physiological param-
eters rarely are documented, knowledge of physical status
or improvements remains uncertain. Therefore, the aim of
the present study was to examine if high-intensity interval
training was feasible for SUD patients in treatment. Further,
we aimed to document their aerobic power and compare
the training group, if they were able to adhere, with patients
receiving conventional treatment in the same clinic. Our
hypotheses were that SUD patients (1) are able to complete a
high-intensity interval training program, (2) have a decreased
aerobic power at baseline compared to the average popula-
tion, and (3) improve their VO2max and work economy more
than the control group receiving conventional rehabilitation.
2. Methods
2.1. Subjects. 24 patients with a diagnosis of substance use
disorder, ICD-10: F10-F19, were included in this study. All
subjects participated in residential long term treatment in a
substance abuse treatment clinic at the time of the study, due
to abuse of illegal drugs. The long term treatment program
at the clinic lasts for ∼3 months. Subjects were excluded if
they had been abstinent or/and systematically participated
in endurance training for the last six months. Subjects were
also excluded if they had cardiovascular disease or chronic
obstructive pulmonary disease or were not able to perform
treadmill testing and training. After signing the written
informed consent, patients were randomized to either a high
intensity training group (TG) or a conventional rehabilitation
control group (CG) (Figure 1). Patient characteristics and
medical use are given in Table 1.The regional ethical commit-
tee did approve the study, and it was carried out in accordance
with the Declaration of Helsinki.
2.2. Testing
2.2.1. Maximal Oxygen Consumption and Work Economy.
Measurements of VO2max, work economy, and ventilatory
parameters were obtained using the Cortex Metamax II
portable metabolic test system (Cortex Biophysik GmbH,
Leipzig, Germany), walking/running on a treadmill (Wood-
way Weil am Rhein, Germany). After a 10-minute warm-up
period, the subjects walked at 4.5 km ⋅ h−1 at 5% inclination
for a period of 5 minutes. The average oxygen consumption
for the last minute of this period was recorded as the work
economy. Immediately following the work economy test, the
BioMed Research International 3
Table 1: Patient characteristics and medical use.
TG
(𝑛 = 9)
CG
(𝑛 = 7)
Combined
(𝑛 = 16)
Men/women (𝑛) 8/1 5/2 13/3
Age (yr) 33 ± 11 31 ± 8 32 ± 9
Height (cm) 177 ± 10 175 ± 10 176 ± 10
Weight (kg) 84.1 ± 14.9 87.9 ± 20.8 85.8 ± 17.2
Current smoker 8 6 14
Drug use debut (age) 15 ± 6 17 ± 4 16 ± 5
Duration of abuse (yr) 17 ± 8 12 ± 4 15 ± 7
Primary drug
Heroin 1 1 2
BZD, Sed, Hypn 1 1 2
Amphetamine 4 4 8
Cannabis 3 1 4
Secondary drug
Alcohol 2 0 2
Heroin 1 1 2
Opiates, painkillers 2 1 3
Amphetamine 1 0 1
Cannabis 3 5 8
Symptoms for medicine
prescription:
ADHD 0 1 1
Allergies 1 2 3
Anxiety 2 1 3
Arthritis 0 1 1
Asthma/COPD 0 1 1
Depression 1 2 3
Epilepsy 0 1 1
Hypertension 3 1 4
Schizophrenia/bipolar 1 2 3
Substitutional treatment 1 1 2
Other 0 3 3
Data are presented as mean ± SD; TG: training group; CG: control group,
Type of medication is reported on indication of symptoms according to
common directory.The prescribed medicines in substitutional treatment are
methadone and suboxone. Others: skin disorder, pain, and inflammation.
subjects continued to the VO2max test. The incline was kept
at 5% while velocity was increased by 1 km ⋅h−1 every minute
until exhaustion. VO2max, respiratory exchange ratio (RER)
and ventilation were calculated averaging the three highest
continuous 10 second values. One or more of the following
criteria for reaching VO2max were considered [21]: (1) if
the oxygen consumption reached a plateau despite further
increases in workload, (2) a RER above 1.05, and (3) lactate
concentration in blood ([La−]b) > 7mmol. Maximal heart
rate (HRmax) was calculated as 4 beats ⋅ min
−1 added to
the highest heart rate during the last minute [22]. For heart
rate assessment Polar F6 heart rate monitors were used
(Polar Electro, Finland). [La−]b were measured using the
Biosen C line (EKF Diagnostics GmbH, Barleben, Germany)
analyzer. Blood from the patient’s fingertip was sampled for
analysis of blood lactate within 1min after the VO2max test.
As an expression of maximal aerobic power, inclination and
velocity at VO2max were registered.
2.2.2. Identification of Drug Use. For identification of the
extent of drug use the first page of EuropASI was applied
(Addiction Severity Index, European adaption ofThe Ameri-
can 5th edition [23]). This index quantifies which substances
have been used, when the patients started their use, and for
how long the dependency has lasted. Further, themedical use
for the patients participating in the study is given in Table 1.
2.2.3. Insomnia, Anxiety, and Depression Questionnaires. In
addition to the physical testing two questionnaires were
implemented; Insomnia Severity Index (ISI) to detect pos-
sible cases of insomnia and Hospital Anxiety and Depres-
sion Scale (HAD) which is used to estimate the levels
of anxiety and depression. These self-report questionnaires
were answered before and after the training intervention as
measures of psychological changes during the period of the
study.The ISI has been evaluated to be a clinically useful tool
for screening and quantifying perceived insomnia severity
[24]. It is composed of 7 items targeting different categories of
sleep disturbance severity. The items are rated at a five-point
Likert scale (0–4) summed up to a total score ranging from 0
to 28, where a higher score indicates more severe insomnia.
The score categories are 0–7 (no clinically significant insom-
nia), 8–14 (subthreshold insomnia), 15–21 (clinical insomnia,
moderate severity), and 22–28 (clinical insomnia, severe).
The HAD self-assessment scale is consisting of a fourteen
item scale, seven items related to anxiety and seven related
to depression. On the subscales for anxiety and depression a
score of 0–7 for either subscale is estimatedwithin the normal
range, while a score of 11 or higher implies a probable presence
of a mood disorder. A score of 8–10 is considered signs of a
mood disorder [25].
2.3. Training Intervention. Both the TG and the CG par-
ticipated in the clinic treatment activities throughout the
8-week intervention period. These activities included: Ball-
games (indoor-soccer and volleyball), yoga, stretching, out-
door walking, low resistance strength training, ceramics,
TV games, and card games. Additionally,the TG received
supervised training 3 times aweek for a period of 8weeks.The
training was performed as inclined walking or running on
a treadmill, using the same heart rate monitor as during the
VO2max testing, to ensure correct intensity of every training
session. The training sessions were organized as interval
training, with 4 × 4 minutes of high aerobic intensity (90–
95% of HRmax), interrupted by 3-minute recovery periods
(∼70% of HRmax) [21]. All training sessions were supervised.
As the subjects improved, velocity and incline were increased
tomeet the targeted heart rate.The subjects needed to have an
adherence of at least 20 out of 24 training sessions in order to
be included in the data analyses.Within the same time period
as the TG performed their high-intensity interval training
on a treadmill, the patients in the CG chose to participate
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Table 2: Changes in physiological parameters from pre- to posttest.
TG (𝑁 = 9) CG (𝑁 = 7)
Pre Post Pre Post
VO2max
(L⋅min−1) 3.60 ± 0.91 4.15 ± 1.03∗∗# 3.43 ± 0.66 3.54 ± 0.65
(mL⋅kg−1⋅min−1) 42.3 ± 7.2 48.7 ± 9.2∗∗# 41.8 ± 12.3 42.6 ± 12.1
𝑉𝐸 (L⋅min
−1) 109.2 ± 28.6 125.9 ± 36.8∗∗# 103.5 ± 24.4 103.2 ± 23.9
RER 1.09 ± 0.03 1.10 ± 0.02 1.17 ± 0.11 1.14 ± 0.06
HRmax (beats⋅min
−1) 180 ± 11 181 ± 14 189 ± 7 188 ± 7
[La−]b 9.12 ± 2.41 10.65 ± 1.69 8.04 ± 3.54 9.21 ± 2.01
Data are presented as mean ± SD. TG: training group; CG: control group; VO2max: maximal oxygen uptake; 𝑉𝐸: ventilation; RER: respiratory exchange ratio;
HRmax: maximal heart rate; [La
−
]b: lactate concentration in blood,
∗∗
𝑃 < 0.01, difference within group from pre- to posttest, #𝑃 < 0.05, differences in changes
from pre- to posttest between groups.
in a self-elected activity among the offered sports or games
in the clinical treatment program. Although representing a
wide range of different activities, they all shared a measured
or estimated intensity level of <70% of HRmax.
2.4. Statistics. Statistical analyses were performed using the
software SPSS, version 20 (Chicago, USA), and figures were
made using the software GraphPad Prism 5 (San Diego,
USA). Relative improvements are given as mean percentage
change. To determine if the data was normal distributed a Q-
Q plot was used. Repeated measures ANOVAs (2 (group) × 2
training status) were used to determine differences between
groups following training. If appropriate, a Tukey post hoc
analysis was used. Unpaired and paired t-tests were used
to detect differences between groups at baseline and within
group following training, respectively. Statistical significance
was accepted at an 𝛼-level of 𝑃 < 0.05. Data are reported
as mean ± SD, unless otherwise noted. Additionally, using
similar statistics, an intention to treat analysis with the use of
last observation carried forward for missing data was carried
out for all the 24 subjects that were randomized to the two
groups. To achieve a statistical power of 80%, 8 patients in
each group needed to complete the study period in order to
observe a 0.375 L ⋅ min−1 improvement difference in mean
VO2max between TG andCG, assuming a SD of 0.25 L⋅min
−1.
These values were based on previous studies from our group
using the same training intervention in other populations.
The drop-out rate in previous studies has been ∼2/10 subjects.
However, considering that this patient population may be
more challenging than average, a higher drop-out rate is
expected. Thus 12 subjects were randomized to each group
to ensure observation of the assumed efficacy difference
between the two groups.
3. Results
11 of the 12 SUD patients in the TG and 7 out of 12 patients
in the CG, respectively, completed their overall intended stay
at the substance use disorder clinic. With regard to the high
intensity training, 3 subjects withdrew from the TG. Two
withdrew due to personal reasons but remained in the clinical
treatment, while one dropped out from both the clinical
treatment and the TG. In the CG 5 subjects dropped out
of the clinical treatment and thus withdrew from the study
without giving any reasons (Figure 1). The SUD patients that
completed the training period carried out 22±1 of the sched-
uled supervised training sessions.The targeted intensity (90–
95% of HRmax) was reached in all completed sessions. None
of the subjects reported any problems or discomfort com-
pleting the training sessions, other than the normal strain
following high intensity exercise.
At baseline, before the withdrawal of subjects from the
study, values for both groups combined were 44 ± 8 (males)
and 34 ± 9 (females) mL ⋅min−1 ⋅ kg−1, respectively. VO2max
significantly (𝑃 < 0.01) improved by 15±7% for the 9 subjects
that completed the TG (Table 2). This improvement was also
significantly (𝑃 < 0.01) different from the CG (Figure 2). In
accordance with the improvement in aerobic power, the TG
also increased velocity and inclination at VO2max from 9.2 ±
2.3 km ⋅ h−1 and 5.6 ± 1.1% at pretest to 9.3 ± 2.2 km ⋅ h−1
and 8.3 ± 2.4% at posttest. The CG showed no within-group
improvement in neither VO2max nor maximal workload.The
TG increased ventilation at VO2max by 14 ± 10%, while there
were no differences within or between groups in RER or
[La−]b at VO2max from pre- to posttest. An intention to treat
analysis, including all 24 participants that were randomized
to either the TG or the CG, did not show different results for
the primary outcomes compared to analysis including only
subjects that completed the study.
Work economy, measured at 5% inclination and 4.5 km ⋅
h−1 on the treadmill, showed no significant differences
between or within the two groups following the training
period (Table 3). However, the heart rate at thework economy
workload significantly (𝑃 < 0.05) decreased by 9 ± 12% in
the TG, but this within-group change was only apparent as a
trend (𝑃 = 0.158) when compared to the CG.
For psychological variables, the TGdisplayed a significant
(𝑃 < 0.05) decrease in depression level following the training
period, whereas the CG had a significant decrease (𝑃 < 0.05)
in anxiety level from pre- to posttest (Table 4). However,
neither of these within-group differences, measured by the
Hospital Anxiety and Depression questionnaire, was appar-
ent as between-group differences.
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Figure 2: Maximal oxygen consumption before and after the training intervention. Data are presented as mean ± SE. ∗𝑃 < 0.01, difference
within group from pre- to posttest, #𝑃 < 0.05, differences in changes from pre- to posttest between groups.
Table 3: Work economy measured at 4.5 km⋅h−1 and 5% inclination at pre- and posttest.
TG (𝑁 = 9) CG (𝑁 = 7)
Pre Post Pre Post
VO2
(L⋅min−1) 1.54 ± 0.24 1.61 ± 0.28 1.70 ± 0.36 1.77 ± 0.43
(ML⋅kg−1⋅min−1) 18.5 ± 1.1 18.9 ± 1.3 19.6 ± 2.3 20.2 ± 1.4
𝑉𝐸 (L⋅min
−1) 35.1 ± 4.4 33.3 ± 5.3 38.3 ± 9.3 41.1 ± 9.0
RER 0.90 ± 0.04 0.89 ± 0.08 0.93 ± 0.05 0.94 ± 0.07
HRmax (beats⋅min
−1) 116 ± 17 105 ± 18 116 ± 18 119 ± 9
Data are presented as mean ± SD. TG: training group; CG: control group; VO2: oxygen uptake; 𝑉𝐸: ventilation; RER: respiratory exchange ratio; HRmax:
maximal heart rate.
Table 4: Psychological changes from pre- to posttest (scores from
the insomnia severity index and hospital anxiety and depression
scale questionnaires).
TG (𝑛 = 9) CG (𝑛 = 7)
Pre Post Pre Post
Anxiety 9.4 ± 3.5 8.6 ± 2.5 9.1 ± 5.3 6.3 ± 3.4∗
Depression 8.5 ± 4.8 5.3 ± 3.9∗ 6.0 ± 3.5 4.6 ± 3.5
Insomnia 10.6 ± 5.4 8.9 ± 5.1 10.9 ± 10.1 9.1 ± 5.0
Data are presented as means ± SD. TG: training group; CG: control group.
∗
𝑃 < 0.05, difference within group from pre- to posttest.
4. Discussion
Since little is known about the aerobic power of SUD patients
in treatment and their lifestyle indicates that they may suffer
a high risk of cardiovascular and lifestyle diseases, this
study sought to investigate the aerobic power of this group
of patients and their response to exercise training of high
intensity. The main findings of the study were as follows
(1) the initial aerobic power at baseline is lower than what
is typically seen in the average population, (2) the SUD
patients improved their aerobic power andwork performance
following the training intervention, thus decreasing the risk
factors for lifestyle diseases, and (3) the training intervention
is applicable as a part of the clinical treatment.
4.1. Reduced Aerobic Power in Patients with Substance Use
Disorder. At inclusion, the SUD patients in the present study
had a baseline VO2max of 44 ± 8 (males) and 34 ± 9 (females)
mL ⋅ min−1 ⋅ kg−1. This is well below age-matched reference
data from the average population [26].The 10%and 16% lower
baselines for the ∼30 year oldmales and females, respectively,
are comparable to the average values observed among 50–
59-year-old healthy subjects [26]. The low aerobic power, as
documented in the current study, is in line with a previous
study displaying VO2max values of 39 (males) and 31mL ⋅
min−1 ⋅kg−1 (females) in SUDpatients [27]. Our study and the
Mamen and Martinsen [27] study are to our knowledge the
only studies to directly assess aerobic power in SUD patients.
However, the assumption of a health-related critical low
aerobic power is also supported by several studies applying
estimations of VO2max [17, 28–31]. Since low aerobic power is
a well-established risk factor for cardiovascular disease and
all-cause mortality [11, 13, 14, 32], it is likely that the low
VO2max observed among SUD patients may, at least in part,
be responsible for the elevated prevalence of cardiovascular
disease and premature death observed in this patient group.
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It is therefore surprising that aerobic power commonly is
not listed as one of the major causes for illnesses, medical
conditions, and early death in SUD patients [3, 4, 6].
4.2. Exercise-Induced Effect on Aerobic Power,Work Load, and
Risk Reduction. As expected, the SUD patients that com-
pleted the supervised eight week treadmill training period in
the current study improved VO2max. In accordance with the
15 ± 7% improvement in VO2max, the TG increased maximal
velocity and inclination at VO2max from 9.2 ± 2.3 km ⋅ h
−1
and 5.6 ± 1.1% at pretest to 9.3 ± 2.2 km ⋅ h−1 and 8.3 ± 2.4%
at posttest. For patient groups with low aerobic capacities,
daily activities are often perceived as strenuous. An improve-
ment in work capacity is therefore typically associated
with an increased wellbeing in everyday life, since it reduces
the relative intensity on the daily tasks [10, 33, 34]. The
improvement in VO2max observed in our study is similar
to what have previously been reported following a whole
body high intensity (>85% of HRmax) training interven-
tion in a wide range of patient groups [7–10, 35, 36],
as well as and in healthy subjects [21, 37] and old sub-
jects [37]. The magnitude of VO2max improvement may
be influenced by training status, age, or pathology [7–
10]. Subjects with a low baseline are, both mathemat-
ically and physiologically, susceptible to larger percent-
age improvements (∼15–35%) than subjects with a higher
baseline (∼6%–13%) [21, 37].
Considering the elevated risk of mortality [3] and car-
diovascular incidents in SUD patients [4], VO2max improve-
ments as demonstrated in the present study are beneficial. A
3.5mL ⋅min−1 ⋅kg−1 improvement in VO2max has been shown
to be associated with a 12% improved chance of survival
[11] and a 15% reduced risk for developing cardiovascular
disease [32].The SUD patients in the present study improved
their VO2max by 6.6mL ⋅ min
−1
⋅ kg−1, indicating that not
only will they have a strongly decreased mortality rate, but
also a considerable reduced risk of developing cardiovascular
disease. After the relatively short-duration training period the
SUD patients restored their VO2max values to a level similar
to the age-matched healthy population [26]. In contrast, it is
thought provoking that conventional clinical treatment did
not improve VO2max. Physical activity is certainly applied
in today’s treatment [20], but clearly this physical activity is
not sufficient to induce improvements in VO2max. Since the
conventional activities are all reported to be carried out with
a low intensity, this may explain the lack of improvement,
as intensity is suggested to be the key factor for VO2max
improvements [21, 38]. Recognizing the high risk for cardio-
vascular disease and mortality in these patients, it is critical
that today’s treatment may have no effect on one of the most
important factors for these conditions.
The exercise-induced improvement in VO2max that was
observed in the TG is likely due to an improvement in
maximal cardiac output, and more specific is the stroke
volumeof the heart since no changeswere observed inHRmax.
Previously the stroke volume has been shown to be the
decisive factor that explains the adaptations to high intensity
training, both in moderately trained healthy subjects [21]
and in untrained coronary artery disease patients [39]. The
∼ 42mL ⋅min−1 ⋅kg−1 (males and females combined) baseline
VO2max in the current study falls between an aerobic power of
∼55 (young, healthy) and ∼27 (coronary artery disease) mL ⋅
min−1 ⋅ kg−1. Although the SUD patients indeed represent a
different group of subjects, it is likely, since the stroke volume
adaptations appear to be similar across different populations,
that also their improvements in VO2max originate from
training-induced changes in maximal stroke volume.
4.3. Training Effect on Insomnia, Anxiety, and Depression. A
positive relationship between exercise and mood disorders
is well-documented [20, 40–44] specifically apparent as
insomnia [40, 45], anxiety [44], and depression disorder
[41, 43, 46] reductions. Therefore, it is surprising that the
large difference between the TG and the CG in aerobic
power and work load following the study period did not
induce detectable differences between groups in any of these
variables. At baseline, the level of mental distress in both
the TG and the CG group was ranged as moderately severe
according to the Insomnia Severity Index and the Hospital
Anxiety and Depression Scale. Both groups scored within
subthreshold for insomnia and within signs of mood disor-
der. Following the study period there was a reduction of the
depression variable within the TG, as well as a reduction of
the anxiety variable within the CG, but these reductions were
not different between the two groups. It is possible that
psychological benefits, as measured by the questionnaires in
our study, are more related to physical activity per se and
not necessarily to aerobic exercise training.Although reduced
depression symptoms may be associated with exercise in
general and not necessarily restricted to the aerobic form
of exercise [15], it should undoubtedly be expected that a
risk reduction of cardiovascular disease and mortality would
cause an improvement of mood disorders and quality of
life [42]. Thus the commonly applied questionnaires that
were used in our study should be able to detect such an
improvement. Our results indicate that a supplement, expan-
sion, or replacement to/of the questionnaires are sought for,
although it is recognized that the relatively small sample size
in the current study may be, in part, responsible for the
nondetectable differences in mood disorders.
4.4. High-Intensity Interval Training: Clinical Implications.
Considering their high rate of nonattendance and discon-
tinuation [47, 48], reflected in the high relapse rates from
clinical treatment [49], an important question in the current
studywaswhether the SUDpatients were able to carry out the
scheduled period of training. To our knowledge there have
not been any previous reports of SUD patients participating
in such an intensive training intervention. The SUD patients
were in our study capable of managing the intensive training,
reflected in the high attendance (22 ± 1 of the total 24 sched-
uled training sessions) for the 9 subjects that completed the
training period. Interestingly, the completion rate was higher
for the TG, both in the current study and in the clinical
treatment, compared to the CG. Only 1 out of 12 patients
in the TG dropped out from clinical treatment (5 subjects
in the CG) and 3 from the training study (5 subjects in the
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CG). Certainly these withdrawals could be due to chance,
but the completion rate is nevertheless a testament to the
feasibility of high-intensity interval training as part of the
clinical treatment. An intention to treat analysis showed no
differences in the main findings of the current study and thus
strengthens the result of an overall beneficial effectiveness of
high-intensity interval training in a clinical setting. Not only
was it feasible to apply this intervention in the clinic, but
additionally the subjects that completed the training reported
no discomfort or pain during the training sessions other than
what should be expected with high intensity training, and not
one single commenced training session was aborted.
Our findings are in line with a previous study applying a
similar training intervention in patients with schizophrenia
[10]. In the Heggelund et al. study [10] the training was
reported to be challenging but feasible. In our study, as
well as in the Heggelund et al. study [10], all trainings were
conducted in presence of a supervisor. This may be favorable
when implementing a training intervention in mentally ill
patients. Mamen et al. [50] emphasized that the relationship
between the patient and the supervisor can prove essential
for the patients motivation and commitment to the project.
Our experience throughout this study supports this notion.
The present study exemplifies that high intensity training
can be applicable for SUD patients in treatment and that the
intensive training is manageable also for this patient group.
Considering the health benefits associated with this training,
it should be implemented as a complementary treatment for
SUD patients.
5. Conclusion
In the present study SUD patients are shown to have a low
aerobic power, and thus they are at risk for developing cardio-
vascular disease. As it is important that SUD patients receive
both a physical and psychological treatments in the clinic and
our results indicate that the conventional treatment is not
sufficient to reduce the risk of cardiovascular disease, high-
intensity interval training should be implemented as part
of the clinical treatment to effectively improve the patient
groups’ aerobic power.
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Abstract
Background: Patients with substance use disorder (SUD) suffer from multiple health and psychosocial problems.
Because poor physical capacities following an inactive lifestyle may indeed contribute to these problems, physical
training is often suggested as an attractive supplement to conventional SUD treatment. Strength training is shown
to increase muscle strength and effectively improve health and longevity. Therefore we investigated the feasibility
and effect of a maximal strength training intervention for SUD patients in clinical treatment.
Methods: 16 males and 8 females were randomized into a training group (TG) and a control group (CG). The TG
performed lower extremities maximal strength training (85-90 % of 1 repetition maximum (1RM)) 3 times a week
for 8 weeks, while the CG participated in conventional clinical activities.
Results: The TG increased hack squat 1RM (88 ± 54 %), plantar flexion 1RM (26 ± 20 %), hack squat rate of force
development (82 ± 29 %) and peak force (11 ± 5 %). Additionally, the TG improved neural function, expressed as
voluntary V-wave (88 ± 83 %). The CG displayed no change in any physical parameters. The TG also reduced anxiety
and insomnia, while the CG reduced anxiety.
Conclusion: Maximal strength training was feasible for SUD patients in treatment, and improved multiple risk
factors for falls, fractures and lifestyle related diseases. As conventional treatment appears to have no effect on
muscle strength, systematic strength training should be implemented as part of clinical practice.
Trial regestration: ClinicalTrials.gov Identifier: NCT02218970 (August 14, 2014).
Keywords: Muscle strength, One repetition maximum, Rate of force development, V-wave, Physical health, Mental
health
Background
In addition to their drug abuse, patients with substance use
disorder (SUD) suffer from multiple health and psycho-
social comorbidities, resulting in a life expectancy 20–30
years less than the general population [1, 2]. Compared to
the average population these patients are more frequently
represented in medical care, with an elevated incidence of
cardiovascular disease [1, 2], diabetes [1, 2], cancer [1, 2],
suicide [1, 2], as well as traumas, falls and fractures [3–5].
Recent findings in our laboratory show that muscle
strength and aerobic fitness are markedly reduced in SUD
patients compared to healthy age-matched individuals [6].
Low muscle strength is associated with increased incidence
of falls and fractures [7, 8], poor mechanical efficiency [9],
elevated risk of cancer [10] and cardiovascular disease [11],
and is even shown to be an independent predictor of all-
cause mortality in both patient populations and healthy
[12–14].
Strength training has become an increasingly common
measure to improve muscle strength in different patient
populations, and effectively reduce the risk of medical
conditions and mortality. Maximal strength training,
with heavy loads (>85 % of 1 repetition maximum
(1RM)) and emphasis on intended concentric velocity
has been successfully applied in multiple patient
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populations in our labs, and is shown to induce particu-
larly large improvements in rate of force development
(RFD) and muscle strength [15–19]. The improvements
in maximal strength and RFD are suggested to pre-
dominantly rely on neural factors, with little or no
change in body mass [9, 18, 20], which results in the
training being even more suitable in populations
where gains in weight are not sought after. Import-
antly, no injuries have been reported following these
interventions, indicating that the training is not only
effective, but also safe. Perhaps even more than the
maximal strength, rapid force development is shown
to be important for functional status, mechanical effi-
ciency, balance adjustments and the prevention of
falls and fractures [21–23]. Because the RFD relies
mainly on neuromuscular properties [24], strength
training applied to induce functional gain in patient
populations should target neural adaptations. Assessed
by the use of evoked reflex recordings, our research
group has previously documented neural adaptations
in both patient and healthy populations following
maximal strength training [17, 25].
Although SUD patients are reported to have low
muscle strength and aerobic capacity [6], there are few
studies of systematic physical training as a part of clin-
ical SUD treatment [26]. While physical activity is com-
monly used in conventional treatment [27], it appears
not to apply a sufficient overload for taxing the muscular
strength. Thus, maximal strength training would likely
offer additional health benefits, and effectively reduce
the risk of medical conditions. In addition to physical
benefits, strength training is shown to have a positive
effect on mental health, reducing anxiety and depres-
sion levels [28–30]. A low muscle strength has even
been shown to independently be associated with an
elevated rate of suicide [31]. In general, adherence to
an exercise regime is also suggested to improve treat-
ment outcomes and possibly reduce relapse rates in
patients suffering from alcohol and substance abuse
[26, 32].
Since physical activity in clinical treatment often ap-
pear random and unstructured [33], without the suffi-
cient overload to produce gains in muscular strength,
the aim of this study was to assess if a maximal
strength training intervention was feasible for SUD
patients, and would yield the previously documented
beneficial physical and mental effects of such a train-
ing regime. We hypothesized that (1) SUD patients
would be able to carry out the 8 week maximal
strength training intervention, and (2) that the train-
ing group would improve maximal strength, RFD, ef-
ferent neural drive, depression, anxiety and insomnia
more than the control group that participated in con-
ventional treatment.
Methods
Subjects
24 patients diagnosed with SUD, classified within ICD-
10: F10-F19 (mental and behavioral disorders due to
psychoactive substance use), were included in the study
from February to March 2013. All subjects participated
in a ~3 month residential long term treatment at a sub-
stance abuse clinic at the University hospital, and had
amphetamine as their primary drug. After providing
their informed consents subjects were randomized to
either a maximal strength training group (TG) or a con-
trol group (CG) participating in conventional activities
(Fig. 1). Subjects were assigned a number between 1
and 24, and randomization was performed using a pub-
licly accessible official website designed for research
randomization (https://www.randomizer.org). Subjects
were excluded if they had been abstinent and/or sys-
tematically participated in strength training for the last
six months. Other exclusion criteria were cardiovascu-
lar or respiratory disease, not being able to carry out
the testing procedure or failure to participate in at least
20/24 training sessions. Patient characteristics and
medical use are shown in Table 1. The study was ap-
proved by the regional ethical committee (REK-nord)
and conducted in accordance with the declaration of
Helsinki.
Extent of drug use
To get an overview of the extent of drug use the first
page of EuropASI was applied [34]. The index quantifies
which substances the subject has used, age at first time
drug use and years of use. Further the clinic provided in-
formation of prescribed medicine for the overall partici-
pating group of patients. Patient characteristics and
medical use are given in Table 1.
Testing procedure
All subjects conducted the testing procedure before and
after the 8 week training intervention. On the day of
testing, neuromuscular measurements (V-wave) were
carried out first, followed by 1RM hack squat, 1RM
plantar flexion and hack squat RFD. After the strength
measurements, psychological questionnaires were filled
out to assess levels of insomnia, anxiety and depression.
Subjects were asked to not engage in any physical train-
ing on the day of testing or the day before.
Strength measurements
One repetition maximum (1RM) was measured in hack
squat and plantar flexion. Hack squat 1RM was obtained
in a hack squat machine (Impulse Fitness IT7006, Shan-
dong, China) angled 45° to vertical. For the plantar
flexion test, the participants were seated in a calf rise ma-
chine (Impulse Health Tech IT7005, Shandong, China),
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with a knee joint angle of ~90°, and performed their lifts
from an ankle joint angle of ~20° dorsiflexion in the lower
position, up to ~30° plantar flexion in the upper position.
Before testing the subjects were familiarized with the test-
ing apparatus during an extensive warm up procedure,
however no additional familiarization session was ar-
ranged. For both hack squat and plantar flexion, 1RM was
achieved by increasing the load by 5-10 kg until the sub-
ject was not able to complete the lift. A three minutes rest
was given between each trial, and correct joint angles were
ensured. 1RM was achieved within 6–9 trials, and the
highest load completed was recorded as 1RM.
RFD was recorded in the hack squat machine with a
force platform at 2000Hz (9286AA, Kistler, Switzerland)
attached to the foot plate. Each subject was given three
attempts with a load corresponding to 80 % of pretest
1RM. Only the best trial was used for analyzes. The sub-
jects were instructed to move slowly down to a knee
Fig. 1 CONSORT flow diagram of study design
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joint angle of 90°, have a short stop to avoid eccentric
action involvement, and then mobilize maximally in the
concentric phase of the movement. Three minutes rest
was given between each trial. The highest concentric
force was recorded as peak force and RFD was calcu-
lated as Δforce between 10 % and 90 % of peak force [9].
Neuromuscular measurements
Neuromuscular measurements were assessed by volun-
tary V-waves, with the subjects seated in a fixed version
of the plantar flexion apparatus used for dynamic
strength measurements. The V-wave method involves
electrical stimulation of the tibial nerve, applied to evoke
reflex potentials and motor potentials in afferent and
efferent nerves. During supramaximal electrical stimula-
tions all afferent and efferent nerve fibers are recruited
simultaneously, and the reflex volley traveling the
muscle spindle reflex circuit will collide with electrically
evoked action potentials traveling antidromically in the
efferent axons. Because of these collisions the reflex vol-
ley will be completely abolished during rest and not
reach the muscle. In contrast, during maximal voluntary
contraction (MVC) the efferent drive to the muscle will
collide with the antidromic potentials, leaving some ef-
ferent axons open for transmission of the reflex. A
higher efferent drive will clear more axons for reflex
transmission, and will thus allow more of the reflex vol-
ley to pass through to the muscle, where it is recorded
as a V-wave. Based on this, the amplitude of V-wave is
used to express the efferent neural drive during MVC.
Reflex potentials were evoked by a current stimulator
(DS7AH, Digitimer, Welwyn Garden City, UK), in the
tibial nerve, in the popliteal fossa. The electrical current
was delivered by gel-coated (Lectron 2 conductive gel,
Pharmaceutical innovations INC, Newark, NJ, USA) bi-
polar felt pad electrodes, 25 mm between tips, 8 mm
diameter (Digitimer, Welwyn Garden City, UK). The
electrodes were held by hand throughout the testing
procedure, and positioned at the site evoking the largest
reflex amplitude. Evoked potentials were recorded
through self-adhesive AG/AgCI electrodes (Ambu, M-
00-S/50, Ballerup, Denmark) placed as recommended by
SENIAM [35] on m. soleus. Before electrode attachment
the skin was carefully preparated to minimize the inter-
electrode impedance; impedance level <5 kΩ were
required. To provide equal conditions from pre- to post-
test, pictures were taken of the electrode placement at
pretest, and used for identical positioning at posttest.
Searching for the maximal direct motor potential
(Mmax) the current intensity was gradually increased by
2–5 mA until the M-wave reached a plateau. Between
70 and 180 mA was needed to evoke Mmax. To validate
the Mmax three supramaximal stimuli at 150 % of the
current intensity needed to reach the plateau were given.
Eight V-waves were evoked during MVC by delivering a
supramaximal (150 %) stimulus at the point where the
subject reached ~90 % of MVC force. Each MVC was
separated by 1 min rest. Only V-wave recordings, in
which the M-wave was > 90 % of Mmax, were used for
analyzes. The maximal V-wave amplitude (Vmax) was
expressed relative to Mmax (V/M-ratio), to allow between
subjects comparisons. Changes in V/M-ratio are used to
express changes in efferent drive following training.
Psychological questionnaires
In addition to the physical testing two questionnaires
were implemented; Insomnia Severity Index (ISI) to
measure level of insomnia, and Hospital Anxiety & De-
pression Scale (HAD), used to estimate symptoms of
anxiety and depression. These self-report questionnaires
were answered in conjunction with the pre- and posttest
Table 1 Patient characteristics and medical use
TG
(n = 9)
CG
(n = 7)
Combined
(n = 16)
Men/Women (n) 6/3 7/0 13/3
Age (yr) 33 ± 9 29 ± 5 32 ± 8
Weight (kg) 80.2 ± 18.2 81.8 ± 9.6 80.9 ± 14.3
Height (cm) 173 ± 10 181 ± 5 177 ± 9
First time drug use (age) 14 ± 2 15 ± 2 14 ± 2
Duration of abuse (yr) 13 ± 10 11 ± 4 12 ± 8
Current Smoker 7 6 13
Primary drug:
Amphetamine 9 7 16
Secondary drug:
Alcohol 4 1 5
Cocaine 1 1
Cannabis 5 5 10
Symptoms for medicine prescription:
ADHD 1 1 2
Allergies 3 4 7
Anxiety 3 3
Arthiritis 2 2
Asthma/COPD 3 1 4
Depression 3 1 4
Epilepsy 1 1
Hypertension 5 5
Schizofenia/Bipolar 4 1 5
Migrene 3 3
Substitutional treatment 1 1
Other 5 1 6
Data are presented as mean ± SD, TG; training group, CG; control group. Type
of medication is reported on indication of symptoms according to common
directory. The prescribed medicine in substitutional treatment is subuxone.
Others: atherothrombosis, diabetes, infections
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of muscular strength, as measures of psychological
changes during the period of the study. The ISI has
been evaluated to be a clinically useful tool for
screening and quantifying perceived insomnia severity
[36]. It is composed of 7 items targeting different cat-
egories of sleep disturbance severity. The items are
rated at a five-point Likert scale (0–4) summed up to
provide a total score ranging from 0–28, where a
higher score indicates more severe insomnia. The score
categories are 0–7 (no clinically significant insomnia), 8–
14 (subthreshold insomnia), 15–21 (clinical insomnia,
moderate severity) and 22–28 (clinical insomnia, severe).
The HAD self-assessment scale consists of a fourteen item
scale, seven items relate to anxiety and seven relate to de-
pression. On the seven item HADS subscales a score of
0–7 for either subscale is estimated within the normal
range, a score of 11 or higher implies a probable presence
of a mood disorder. A score of 8–10 is considered signs of
a mood disorder [37].
Training intervention
Both the TG and the CG attended the regular treatment
program at the substance abuse clinic during the inter-
vention period. The treatment program activities in-
cluded: Ballgames (indoor-soccer, bandy and volleyball),
yoga, stretching, outdoor walking, low resistance
strength training (estimated <50 % of 1RM), ceramics,
TV games and card games. Together this resulted in a
total of ~3 h of physical activity per week. In addition,
the TG received maximal strength training 3 times a
week for a period of 8 weeks. The training intervention
consisted of two exercises; hack squat and plantar
flexion. Both exercises consisted of 4 sets of 4–5 repeti-
tions, corresponding to 85-90 % of 1RM. The training
load was increased with 5 kg if 5 repetitions were ac-
complished in the last set. Both exercises were con-
ducted with a slow controlled movement in the
eccentric phase, a short stop, and then maximal
mobilization of force in the concentric movement. Hack
squat was performed with 90° knee joint angle, while the
plantar flexion exercise was performed from an ankle
joint angle of ~20° dorsiflexion up to ~30° plantar
flexion. Every training session was supervised to ensure
proper technique and progression throughout the train-
ing period. While the TG participated in the supervised
strength training, the CG chose to participate in self-
elected supervised activities among the offered sports or
games in the clinical treatment program.
Statistical analyzes
Statistical analyzes were done using IBM SPSS Statistics
21 (Chicago, IL, USA), while figures were created using
GraphPad Prism 5 (San Diego, USA). Independent and
paired t tests were used to examine differences between
groups at baseline and within groups following training,
respectively. Between group differences following train-
ing were determined by use of two-way repeated ANO-
VAS. The Pearson test for linear regression was applied
to assess correlations. Statistical significance level was
set to p < 0.05. All variables exhibited normal distribu-
tion, as confirmed by quantile-quantile plots. Data are
presented as mean ± SD unless otherwise noted.
Results
Completion
Of the 24 patients that were included in the study, 16
subjects completed the study period. 3 patients in the
TG dropped out of the clinical treatment, and hence
also dropped out of the study. In the CG 5 subjects
dropped out; 3 patients dropped out of clinical treat-
ment, 1 patient were not able to complete the testing
procedure and 1 patient died from drug overdose. The
withdrawal in the two groups resulted in an uneven dis-
tribution of genders, leaving no females in the CG at
posttest. The participants in the TG adhered to 23 ± 1 of
the 24 scheduled training sessions during the training
period. The patients completed all commenced training
sessions and the targeted intensity (85–90 % of 1RM)
was reached in all sessions.
Muscle strength measurements
For the 16 subjects that completed the study, there was
no significant difference between the TG and the CG in
any of the measured strength parameters at pretest.
After 8 weeks of maximal strength training the TG in-
creased 1RM hack squat by 88 ± 54 % (p < 0.01) (Fig. 2),
whereas plantar flexion 1RM increased from 98 ± 23 kg
to 121 ± 17 kg (26 ± 20 %, p < 0.01). The TG also in-
creased RFD by 82 ± 28 % (p < 0.01) (Fig. 3), whereas
peak force increased from 1846 ± 357 N to 2045 ± 415 N
(11 ± 5 %, p < 0.01). No significant changes were ob-
served in the CG for any of the strength parameters.
Neuromuscular measurements
Maximal strength training led to an enhanced efferent
neural drive in the TG. Following the 8 week training
intervention the TG increased m. soleus Vmax from
1583 ± 1596μv to 2189 ± 1375μv (92 ± 95 % (p < 0.01)).
As there was no observed change in m. soleus Mmax
(6379 ± 2188μv vs. 6332 ± 2244μv), this resulted in an
88 ± 83 % (p < 0.01) increase in m. soleus V/M-ratio
(Fig. 4). No significant changes were observed for
the CG. Finally, ΔV/M-ratio correlated with Δhack
squat 1RM (r = 0.44, p < 0.05) and Δplantar flexion
1RM (r = 0.57, p < 0.05).
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Psychosocial variables
Both the TG and the CG scored within “probable presence
of mood disorder” at inclusion, with elevated scores of
anxiety and insomnia. Following the study period both the
TG and the CG displayed significant within group reduc-
tions in anxiety level (p < 0.05), while the level of insomnia
significantly decreased only in the TG (p < 0.05) (Table 2).
Also the level of depression tended to decrease in both
groups (p = 0.11 for the TG and p = 0.10 for the CG).
Neither of the within group differences were apparent as
between-group differences.
Discussion
Main findings
SUD patients suffer from physical and psychological
deconditioning as a consequence of their detrimental
lifestyle. Since strength training is documented to im-
prove both physical and mental health, we sought to in-
vestigate the feasibility and efficiency of a maximal
strength training regime for a group of SUD patients in
residential treatment. The main findings were that 1) A
maximal strength training intervention was feasible for
SUD patients in treatment, 2) Maximal strength training
effectively improved maximal strength and muscle force
development characteristics, likely caused by alterations
in the central nervous system, 3) Anxiety and insomnia
were improved following the clinical treatment period.
Improved maximal strength and muscle force
development characteristics
As expected the SUD patients that completed the
strength training intervention displayed large improve-
ments in all the measured strength parameters. The
88 % increase in hack squat 1 RM after 8 weeks of
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Fig. 2 Hack squat one repetition maximum (1RM) for (a) the training
group and (b) the control group from pre- to posttest. * p < 0.01,
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Fig. 3 Hack squat rate of force development for (a) the training
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Fig. 4 Data are presented as mean ± SE. Maximal V-wave/maximal
M-wave (V/M-ratio) for the training group at pre- and posttest.
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training is even somewhat higher than most previous
maximal strength training studies, typically ranging be-
tween 25–45 % [9, 18, 19, 38, 39]. Since familiarization
was included as a part of the training intervention in this
study, this likely contributed to the large strength gain.
Additionally, the very low baseline of the weakest sub-
ject, which allowed for a very large percentage improve-
ment of ~200 %, also contributed to the high percentage
improvement of the TG. Nevertheless, our findings dem-
onstrate the large strength gain achievable when heavy
loads and maximal intended concentric velocity are em-
phasized in strength training. Recognizing that the low
physical baseline of the patients in the current study al-
lows large training adaptations, both physiologically and
mathematically, the large increase in hack squat 1RM
highlights the clinical benefit of a high intensity training
intervention in effective physical rehabilitation. The
health benefits from an 88 % improvement in leg muscle
strength are unquestionable. Ortega et al. [31] reported
that Swedish men with high muscular strength had 35 %
lower risk of developing cardiovascular disease, 15–65 %
lower risk of having any psychiatric diagnosis and 20 %
lower risk of all cause mortality when compared to men
with low muscle strength. Also Ruiz et al. [10, 12] found
the risk of mortality from cancer, cardiovascular disease
and other causes to be inversely correlated with muscle
strength. Both the Ortega et al. (2012) study and the
Ruiz et al. [10, 12] studies emphasize that subjects with
low and very low muscle strength particularly suffer an
increased risk of medical complications. Considering
this, increasing the strength of the weakest individuals
would provide the largest health benefit. Although we
did not compare our subjects with a reference group
some of the patients in the current study stood out as
particularly weak. Interestingly it was these patients who
apparently seemed to benefit the most from the training.
This visual observation was also reflected in the psycho-
social questionnaires, where the three weakest subjects
exhibited substantial improvements in the psychosocial
variables following the training period.
High muscle strength is also associated with lower risk
of falls and fractures [7, 8]. Moreland et al. [40] reported
that subjects with low and very low muscle strength ex-
hibited elevated risk of single and recurrent falling
(Odds ratio: 1.31–5.06). Considering the high incidence
of non-drug related hospitalizations among SUD-
patients, typically including traumas, falls and fractures
[3–5], it is likely that the improved muscle strength
would have a preventive effect on these high injury- and
hospitalization rates. Balance adjustments and fall pre-
vention do not only require maximal strength; the ability
of rapid muscle contractions is often just as important,
since the time frame to avoid a fall is short [21, 22, 41].
Because strength training with heavy loads and maximal
concentric mobilization is associated with large gain in
explosive strength, maximal strength training is argued
to be particularly beneficial to induce gain in motor
function. The 82 % increase in RFD in the current study
adds evidence of the large improvements in explosive
strength following maximal strength training regimes,
and is similar to previous reports from our research
group [18, 38, 39].
Neuromuscular alterations and maximal strength training
The ~ twofold increase in V/M-ratio highlights that
neuromuscular changes largely contributed to the gain
in muscle strength. Although there is agreement that
training-induced changes in muscle strength relies on a
combination of neuromuscular and anabolic adaptations
[42], studies involving maximal strength training have
often claimed that the improvements were mainly of
neuromuscular origin, due to large improvements in 1RM
and RFD, with no change in body weight [9, 18, 20]. Based
on the comparable large improvements in V/M-ratio and
maximal strength, as well as the lack of change in body
weight, our findings are in line with this notion. It is un-
likely that the low number of repetitions, and thus low
anabolic effect, was sufficient to induce any significant
muscle growth, while the heavy loads and maximal
mobilization seems to be optimal for neural adaptations
[20, 43]. The 88 % increase in V/M-ratio is slightly higher
compared to other strength training studies, typically dis-
playing improvements of 50–80 % [44, 45]. However, these
interventions have been conducted with a lower training
intensity than the current, consequently also resulting in
smaller improvements maximal strength. Therefore, in
combination, our findings and previous studies, exhibits
corresponding improvements in neuromuscular adapta-
tions and muscular strength. Specifically, the changes in
V-wave amplitude in the current study likely reflects an
enhanced efferent neural drive to the muscle, probably
due to increased motor unit firing frequency and/or in-
creased motoneuron recruitment [44, 46]. This is because
a higher efferent drive would allow more of the electrically
Table 2 Psychological measurements, changes from pre- to
posttest (scores from insomnia severity index and hospital
anxiety and depression scale questionnaires)
TG (n = 9) CG (n = 7)
Pre Post Pre Post
Anxiety (0–21) 12.3 ± 5.8 6.3 ± 3.9 * 11.1 ± 4.5 8.0 ± 4.8 *
Depression (0–21) 5.2 ± 2.1 3.0 ± 1.6 7.4 ± 4.7 4.9 ± 3.8
Insomnia (0–28) 9.2 ± 6.5 3.0 ± 2.0 * 13.3 ± 6.2 10.1 ± 5.3
Data are presented as mean ± SD, TG; Training group, CG; Control group.
Score categories anxiety and depression: Normal (0–7); signs of mood
disorder (8–10); probable presence of mood disorder (11–21). Score
categories insomnia: No clinically significant insomnia (0–7); subthreshold
insomnia (8–14); clinical insomnia, moderate severity (15–21); clinical
insomnia, severe (22–28). * p < 0.05, difference within group pre- to posttest
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evoked reflex volley to pass through to the muscle, hence
resulting in the increased amplitude of the V-wave.
Feasibility of maximal strength training in substance use
clinical treatment
The 75 % completion rate of the TG in the current study
exemplifies that although maximal strength training may
be considered strenuous, SUD patients are in general
capable of engaging in physically demanding training re-
gimes. To date there have been few studies examining
intensive physical training in SUD patients, but we have
recently shown that also intensive endurance training is
feasible for this patient group [33]. In agreement with
our findings from the endurance training study, the SUD
patients reported no difficulties carrying out the strength
training, and the targeted intensity (85–90 % of 1 RM)
was reached in all commenced training sessions, without
any reports of pain or discomfort. Importantly, most of
the subjects that participated reported that they found
the simple and robust training motivating, and that they
enjoyed observing their own steady and impressing large
progression throughout the study. Although SUD is
commonly associated with high rates of nonattendance
and relapse [47, 48], we experienced no issues regarding
subject compliance and attendance to the scheduled
training sessions. None of the participating subjects in
clinical treatment dropped out solely from the training
intervention. Despite being simple and time-efficient to
carry out, the training intervention likely benefits from
supervision from a trained professional to provide com-
mitment to, and understanding of, the training regime.
This notion is also in agreement with previous studies
employing training interventions in SUD-patients [33,
49]. Notably, our experience involves only patients par-
ticipating in residential treatment. It should therefore be
considered that the same feasibility and completion rates
may not apply for outpatients.
Maximal strength training and psychosocial health
The SUD patients in the current study revealed signifi-
cant signs of mood disorder at inclusion, reflected in ele-
vated scores of anxiety and insomnia. The TG showed a
reduction in both anxiety and insomnia scores, as well
as a trend towards less depression. However, a reduction
in depression following endurance training has previ-
ously been reported [33]. In combination, this is evi-
dence that effective, intensive exercise training is not
mentally harmful but, again, feasible. Since these im-
provements in this study are not significantly different
from the CG it is difficult to conclude whether the men-
tal health improvements were related to the clinical
treatment itself or if they were a result of the improve-
ments in muscle strength. Physical activity is in general
shown to positively affect mental health [29], and it may
therefore be that the mental health improvements are
more related to physical activity performed by both
groups, rather than the improvements in muscle
strength. However, given the large beneficial effect of an
improved physical capacity, and the substantial risk-
reduction for diseases and thus likely improvement in
quality of life, a clinical treatment including effective
physical training should be advocated. Indeed, a close as-
sociation between physical training and mental health
has previously been reported [50–52]. Furthermore, it
should be questioned whether self-reporting question-
naires that are not able to detect large training-induced
decreases in risk of lifestyle-related diseases are good
enough.
Clinical considerations for effective physical training in
clinical treatment
Recognizing the close relationship between physical cap-
acities, life style related diseases and mortality [10, 53], it
is likely that implementation of effective physical train-
ing as standard part of the treatment for SUD patients
would decrease the high rates of non-drug related hospi-
talizations. This study shows that maximal strength
training not only is feasible as a part of the treatment, it
also has a large effect size and is time efficient. Previ-
ously we have shown similar findings for endurance
training [33]. Adding to the arguments for implementa-
tion of effective physical training in the clinic is also the
poor rehabilitation results observed in the CG participat-
ing in conventional physical activity. The current study
observed that the muscular strength and force character-
istics in the CG remained unchanged following the
8 week period. In a previous study similar observations
were also reported for endurance capacity [33]. Al-
though SUD patients suffer from many challenges, it is
important to recognize that their physical health consti-
tutes an important part of the overall health. Since
muscle strength and aerobic capacity are known to be
important contributors to the physical health, we would
argue that strength- and endurance training should be
carried out concurrently in clinical SUD treatment. Not
only are these physical characteristics shown to be very
low in SUD patients [6], today’s treatment also appears
to have very limited, if any endurance and strength
effects. Importantly, this study, as well as a recent endur-
ance training study [33] suggests that effective strength-
and endurance training regimes are feasible and safe to
carry out within this patient group.
Interestingly, the dropout rate in the TG (3 subjects) in
the current study was lower than in the CG (5 subjects).
Again, a similar finding was documented following
endurance training (3 subjects) vs. conventional treatment
(5 subjects) [33]. It is also of importance that the three
subjects that dropped out of this study dropped out of the
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general clinical treatment, and not solely the adherence to
the maximal strength training intervention. In support of
this notion, it has previously been suggested that partici-
pation and adherence to an exercise program may have a
positive effect on the relapse rates during alcohol recovery
[32]. In combination, these findings suggest that imple-
mentation of effective physical training will improve the
patients’ physical health more than conventional treat-
ment, and it is likely that it may also lead to gains in psy-
chosocial health.
Study limitations
The training-induced changes of the main physiological
variables were statistical significant in this study. How-
ever, a larger sample size may have been beneficial for
the psychosocial variables, or perhaps a replacement by
more detailed psychosocial questionnaires. While this
study exemplifies that high intensity strength training is
effective and feasible in SUD treatment, it should be
noted that all patients in the current study had amphet-
amine as their primary drug, and that they were all re-
cruited from the same clinic. While the conventional
treatment in this clinic did not have any effect on the
physical variables, it cannot be excluded that other
clinics may have more effective treatment programs.
Similarly, it can also be questioned whether our results
would have been different if we had included patients
with other primary drugs than amphetamine. As both
patient characteristics and clinical treatment programs
may vary between clinics, future studies should aim to
investigate the effect of effective physical training in
multiple clinics, and also aim for larger sample sizes to
target psychosocial variables and include patients with
different primary drugs.
Conclusion
This study shows that maximal strength training is a
feasible, safe and effective method to improve muscle
strength and function during SUD treatment. The large
improvements in maximal strength and RFD that were
observed following two months of training seemed to
rely largely on neuromuscular adaptations. The improve-
ments in physical health implies that the SUD patients
have reduced their risk for traumas, falls and fractures,
life style related diseases and all-cause mortality. Recog-
nizing the poor physical condition of SUD patients, ef-
fective physical training, targeting muscle strength and
aerobic capacity should be implemented in clinical treat-
ment to improve physical and mental health.
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